Document:

Rights Agreement, dated November 14, 2002

 EXHIBIT 4.1 
  
 
 
 DAVITA INC. 
  
 and 
  
 THE BANK OF NEW YORK, as Rights Agent 
  

 
 RIGHTS AGREEMENT 
  
 Dated as of November 14, 2002 
  
 

  
 TABLE OF CONTENTS 
 
	  	  	  	  	 Page
 

	 
	 Section 1.
 	  	 Certain Definitions
 	  	 1
 
	 
	 Section 2.
 	  	 Appointment of Rights Agent
 	  	 5
 
	 
	 Section 3.
 	  	 Issue of Right Certificates
 	  	 5
 
	 
	 Section 4.
 	  	 Form of Right Certificates
 	  	 7
 
	 
	 Section 5.
 	  	 Countersignature and Registration
 	  	 7
 
	 
	 Section 6.
 	  	 Transfer, Split Up, Combination and Exchange of Right Certificates; Mutilated, Destroyed, Lost or Stolen Right
Certificates
 	  	 8
 
	 
	 Section 7.
 	  	 Exercise of Rights, Purchase Price; Expiration Date of Rights
 	  	 9
 
	 
	 Section 8.
 	  	 Cancellation and Destruction of Right Certificates
 	  	 10
 
	 
	 Section 9.
 	  	 Availability of Shares of Common Stock
 	  	 10
 
	 
	 Section 10.
 	  	 Common Stock Record Date
 	  	 11
 
	 
	 Section 11.
 	  	 Adjustment of Purchase Price, Number and Kind of Shares and Number of Rights
 	  	 12
 
	 
	 Section 12.
 	  	 Certificate of Adjusted Purchase Price or Number of Shares
 	  	 18
 
	 
	 Section 13.
 	  	 Consolidation, Merger or Sale or Transfer of Assets or Earning Power
 	  	 19
 
	 
	 Section 14.
 	  	 Fractional Rights and Fractional Shares
 	  	 22
 
	 
	 Section 15.
 	  	 Rights of Action
 	  	 23
 
	 
	 Section 16.
 	  	 Agreement of Right Holders
 	  	 23
 
	 
	 Section 17.
 	  	 Right Certificate Holder Not Deemed a Stockholder
 	  	 24
 
	 
	 Section 18.
 	  	 Concerning the Rights Agent
 	  	 24
 
	 
	 Section 19.
 	  	 Merger or Consolidation or Change of Name of Rights Agent
 	  	 25
 
	 
	 Section 20.
 	  	 Duties of Rights Agent
 	  	 25
 

 

  
 
	 
	 Section 21.
 	  	 Change of Rights Agent
 	  	 27
 
	 
	 Section 22.
 	  	 Issuance of New Right Certificates
 	  	 28
 
	 
	 Section 23.
 	  	 Redemption
 	  	 28
 
	 
	 Section 24.
 	  	 Exchange
 	  	 29
 
	 
	 Section 25.
 	  	 Notice of Certain Events
 	  	 30
 
	 
	 Section 26.
 	  	 Notices
 	  	 31
 
	 
	 Section 27.
 	  	 Supplements and Amendments
 	  	 31
 
	 
	 Section 28.
 	  	 Successors
 	  	 32
 
	 
	 Section 29.
 	  	 Benefits of this Agreement
 	  	 32
 
	 
	 Section 30.
 	  	 Determinations and Actions by the Board of Directors
 	  	 32
 
	 
	 Section 31.
 	  	 Severability
 	  	 32
 
	 
	 Section 32.
 	  	 Governing Law
 	  	 32
 
	 
	 Section 33.
 	  	 Counterparts
 	  	 32
 
	 
	 Section 34.
 	  	 Descriptive Headings
 	  	 33
 

 

 RIGHTS AGREEMENT 
  
 Rights Agreement, dated as of November 14, 2002 (“Agreement”), between DaVita Inc., a Delaware corporation (the “Company”), and The Bank of New York, as Rights Agent (the
“Rights Agent”). 
  
 The Board of Directors of the Company has authorized and declared a dividend of one
common share purchase right (a “Right”) for each share of Common Stock (as hereinafter defined) of the Company outstanding as of the Close of Business (as defined below) on November 29, 2002 (the “Record Date”), each Right
representing the right to purchase one share of Common Stock (subject to adjustment as hereinafter provided), upon the terms and subject to the conditions herein set forth, and has further authorized and directed the issuance of one Right (subject
to adjustment as provided herein) with respect to each share of Common Stock that shall become outstanding between the Record Date and the earlier of the Distribution Date and the Expiration Date (as such terms are hereinafter defined);
provided, however, that Rights may be issued with respect to shares of Common Stock that shall become outstanding after the Distribution Date and prior to the Expiration Date in accordance with Section 22. 
  
 Accordingly, in consideration of the premises and the mutual agreements herein set forth, the parties hereby agree as follows:

  
 Section 1.  Certain Definitions.  For purposes of this Agreement, the following terms
have the meaning indicated: 
  
 (a)    “Acquiring Person” shall mean any Person (as
such term is hereinafter defined) who or which shall be the Beneficial Owner (as such term is hereinafter defined) of 15% or more of the shares of Common Stock then outstanding, but shall not include an Exempt Person (as such term is hereinafter
defined); provided, however, that (i) if the Board of Directors of the Company determines in good faith that a Person who would otherwise be an “Acquiring Person” became the Beneficial Owner of a number of shares of Common
Stock such that the Person would otherwise qualify as an “Acquiring Person” inadvertently (including, without limitation, because (A) such Person was unaware that it beneficially owned a percentage of Common Stock that would otherwise
cause such Person to be an “Acquiring Person” or (B) such Person was aware of the extent of its Beneficial Ownership of Common Stock but had no actual knowledge of the consequences of such Beneficial Ownership under this Agreement) and
without any intention of changing or influencing control of the Company, then such Person shall not be deemed to be or to have become an “Acquiring Person” for any purposes of this Agreement unless and until such Person shall have failed
to divest itself, as soon as practicable (as determined, in good faith, by the Board of Directors of the Company), of Beneficial Ownership of a sufficient number of shares of Common Stock so that such Person would no longer otherwise qualify as an
“Acquiring Person”; (ii) if, as of the date hereof or prior to the first public announcement of the adoption of this Agreement, any Person is or becomes the Beneficial Owner of 15% or more of the shares of Common Stock 

 
 -1- 

 outstanding, such Person shall not be deemed to be or to become an “Acquiring Person” unless and until such time as such Person shall,
after the first public announcement of the adoption of this Agreement, become the Beneficial Owner of additional shares of Common Stock (other than pursuant to a dividend or distribution paid or made by the Company on the outstanding Common Stock or
pursuant to a split or subdivision of the outstanding Common Stock), unless, upon becoming the Beneficial Owner of such additional shares of Common Stock, such Person is not then the Beneficial Owner of 15% or more of the shares of Common Stock then
outstanding; and (iii) no Person shall become an “Acquiring Person” as the result of an acquisition of shares of Common Stock by the Company which, by reducing the number of shares outstanding, increases the proportionate number of shares
of Common Stock beneficially owned by such Person to 15% or more of the shares of Common Stock then outstanding, provided, however, that if a Person shall become the Beneficial Owner of 15% or more of the shares of Common Stock then
outstanding by reason of such share acquisitions by the Company and shall thereafter become the Beneficial Owner of any additional shares of Common Stock (other than pursuant to a dividend or distribution paid or made by the Company on the
outstanding Common Stock or pursuant to a split or subdivision of the outstanding Common Stock), then such Person shall be deemed to be an “Acquiring Person” unless upon becoming the Beneficial Owner of such additional shares of Common
Stock such Person does not beneficially own 15% or more of the shares of Common Stock then outstanding. For all purposes of this Agreement, any calculation of the number of shares of Common Stock outstanding at any particular time, including for
purposes of determining the particular percentage of such outstanding shares of Common Stock of which any Person is the Beneficial Owner, shall be made in accordance with the last sentence of Rule 13d-3(d)(1)(i) of the General Rules and Regulations
under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as in effect on the date hereof. 
  
 (b)    “Affiliate” and “Associate” shall have the respective meanings ascribed to such terms in Rule 12b-2 of the General Rules and Regulations under the Exchange Act, as in effect on the date
hereof. 
  
 (c)    A Person shall be deemed the “Beneficial Owner” of, shall be deemed
to have “Beneficial Ownership” of and shall be deemed to “beneficially own” any securities: 
  
          (i)    which such Person or any of such Person’s Affiliates or Associates is deemed to beneficially own, directly or indirectly, within the meaning of
Rule l3d-3 of the General Rules and Regulations under the Exchange Act as in effect on the date hereof; 
  
          (ii)  which such Person or any of such Person’s Affiliates or Associates has (A) the right to acquire (whether such right is exercisable immediately or only after
the passage of time) pursuant to any agreement, arrangement or understanding (other than customary agreements with and between underwriters and selling group members with respect to a bona fide public offering of securities), or upon the exercise of
conversion rights, exchange rights, rights, warrants or options, or otherwise; provided, however, that a Person shall not be deemed the Beneficial Owner of, or to beneficially own, (x) securities tendered pursuant to a tender or
exchange offer made by or on behalf of such Person or any of such 

 
 -2- 

 Person’s Affiliates or Associates until such tendered securities are accepted for purchase, (y) securities which such Person has a right to
acquire upon the exercise of Rights at any time prior to the time that any Person becomes an Acquiring Person or (z) securities issuable upon the exercise of Rights from and after the time that any Person becomes an Acquiring Person if such Rights
were acquired by such Person or any of such Person’s Affiliates or Associates prior to the Distribution Date or pursuant to Section 3(a) or Section 22 hereof (“Original Rights”) or pursuant to Section 11(i) or Section 11(n) with
respect to an adjustment to Original Rights; or (B) the right to vote pursuant to any agreement, arrangement or understanding; provided, however, that a Person shall not be deemed the Beneficial Owner of, or to beneficially own, any
security by reason of such agreement, arrangement or understanding if the agreement, arrangement or understanding to vote such security (1) arises solely from a revocable proxy or consent given to such Person in response to a public proxy or consent
solicitation made pursuant to, and in accordance with, the applicable rules and regulations promulgated under the Exchange Act and (2) is not also then reportable on Schedule 13D under the Exchange Act (or any comparable or successor report); or

  
          (iii)    which are beneficially owned,
directly or indirectly, by any other Person and with respect to which such Person or any of such Person’s Affiliates or Associates has any agreement, arrangement or understanding (other than customary agreements with and between underwriters
and selling group members with respect to a bona fide public offering of securities) for the purpose of acquiring, holding, voting (except to the extent contemplated by the proviso to Section 1(c)(ii)(B)) or disposing of such securities of the
Company; 
  
 provided, however, that no Person who is an officer, director or employee of an Exempt Person shall be deemed,
solely by reason of such Person’s status or authority as such, to be the “Beneficial Owner” of, to have “Beneficial Ownership” of or to “beneficially own” any securities that are “beneficially owned” (as
defined in this Section l(c)), including, without limitation, in a fiduciary capacity, by an Exempt Person or by any other such officer, director or employee of an Exempt Person. 
  
 (d)    “Business Day” shall mean any day other than a Saturday, a Sunday or a day on which banking institutions in the State of New York or
the city in which the principal office of the Rights Agent is located are authorized or obligated by law or executive order to close. 
  
 (e)    “Close of Business” on any given date shall mean 5:00 P.M., New York City time, on such date; provided, however, that if such date is not a Business Day it shall mean 5:00
P.M., New York City time, on the next succeeding Business Day. 
  
 (f)    “Common
Stock” when used with reference to the Company shall mean the Common Stock, presently par value $0.001 per share, of the Company. “Common Stock” when used with reference to any Person other than the Company shall mean the common stock
(or, in the case of an unincorporated entity, the equivalent equity interest) with the greatest voting power of such other Person or, if such other Person is a Subsidiary of another Person, the Person or Persons which ultimately control such
first-mentioned Person. 

 
 -3- 

  
 (g)    “Common Stock Equivalents” shall have the
meaning set forth in Section 11(a)(ii) hereof. 
  
 (h)    “Current Value” shall have
the meaning set forth in Section 11(a)(ii) hereof. 
  
 (i)    “Distribution Date” shall
have the meaning set forth in Section 3 hereof. 
  
 (j)    “Equivalent Common Shares”
shall have the meaning set forth in Section 11(b) hereof. 
  
 (k)    “Exempt Person”
shall mean the Company or any Subsidiary (as such term is hereinafter defined) of the Company, in each case including, without limitation, in its fiduciary capacity, or any employee benefit plan of the Company or of any Subsidiary of the Company, or
any entity or trustee holding Common Stock for or pursuant to the terms of any such plan or for the purpose of funding any such plan or funding other employee benefits for employees of the Company or of any Subsidiary of the Company. 

 
 (l)    “Exchange Ratio” shall have the meaning set forth in Section 24 hereof. 

 
 (m)    “Expiration Date” shall have the meaning set forth in Section 7 hereof. 

 
 (n)    “Final Expiration Date” shall have the meaning set forth in Section 7 hereof.

  
 (o)    “Flip-In Event” shall have the meaning set forth in Section 11(a)(i) hereof.

  
 (p)    “NASDAQ” shall mean The Nasdaq Stock Market. 
  
 (q)    “New York Stock Exchange” shall mean the New York Stock Exchange, Inc. 
  
 (r)    “Person” shall mean any individual, firm, corporation, partnership, limited liability company, trust
or other entity, and shall include any successor (by merger or otherwise) to such entity. 
  
 (s)    “Principal Party” shall have the meaning set forth in Section 13(b) hereof. 
  
 (t)    “Purchase Price” shall have the meaning set forth in Section 7(b) hereof. 
  
 (u)    “Redemption Date” shall have the meaning set forth in Section 7 hereof. 
  
 (v)    “Redemption Price” shall have the meaning set forth in Section 23 hereof. 
  
 (w)    “Right Certificate” shall have the meaning set forth in Section 3 hereof. 

 
 -4- 

  
 (x)      “Securities Act” shall mean the
Securities Act of 1933, as amended. 
  
 (y)      “Section 11(a)(i) Trigger
Date” shall have the meaning set forth in Section 11(a)(ii) hereof. 
  
 (z)      “Spread” shall have the meaning set forth in Section 11(a)(ii) hereof. 
  
 (aa)    “Stock Acquisition Date” shall mean the first date of public announcement (which, for purposes of this definition, shall include, without limitation, a report filed pursuant to Section
13(d) of the Exchange Act) by the Company or an Acquiring Person that an Acquiring Person has become such, or such earlier date as a majority of the Board of Directors of the Company shall become aware of the existence of an Acquiring Person.

  
 (bb)    “Subsidiary” of any Person shall mean any corporation or other entity of
which securities or other ownership interests having ordinary voting power sufficient to elect a majority of the board of directors or other persons performing similar functions are beneficially owned, directly or indirectly, by such Person, and any
corporation or other entity that is otherwise controlled by such Person. 
  
 (cc)    “Substitution Period” shall have the meaning set forth in Section 11(a)(ii) hereof. 
  
 (dd)    “Summary of Rights” shall have the meaning set forth in Section 3 hereof. 
  
 (ee)    “Trading Day” shall have the meaning set forth in Section 11(d)(i) hereof. 
  
 Section 2.  Appointment of Rights Agent.  The Company hereby appoints the Rights Agent to act as agent for the Company and the holders of the Rights (who, in accordance with Section 3 hereof, shall
prior to the Distribution Date be the holders of Common Stock) in accordance with the terms and conditions hereof, and the Rights Agent hereby accepts such appointment. The Company may from time to time appoint such co-Rights Agents as it may deem
necessary or desirable. 
  
 Section 3.  Issue of Right Certificates. 
  
 (a)    Until the Close of Business on the earlier of (i) the tenth day after the Stock Acquisition Date or (ii) the
tenth Business Day (or such later date as may be determined by action of the Board of Directors of the Company prior to such time as any Person becomes an Acquiring Person) after the date of the commencement by any Person (other than an Exempt
Person) of, or of the first public announcement of the intention of such Person (other than an Exempt Person) to commence, a tender or exchange offer the consummation of which would result in any Person (other than an Exempt Person) becoming the
Beneficial Owner of shares of Common Stock aggregating 15% or more of the Common Stock then outstanding (the earlier of such dates being herein referred to as the “Distribution Date”, provided, however, that if either of such
dates occurs after the date of this Agreement and on or prior to the Record 

 
 -5- 

 Date, then the Distribution Date shall be the Record Date), (x) the Rights will be evidenced (subject to the provisions of Section 3(b) hereof)
by the certificates for Common Stock registered in the names of the holders thereof and not by separate Right Certificates, and (y) the Rights will be transferable only in connection with the transfer of Common Stock. As soon as practicable after
the Distribution Date, the Company will prepare and execute, the Rights Agent will countersign and the Company will send or cause to be sent (and the Rights Agent will, if requested, send) by first-class, insured, postage-prepaid mail, to each
record holder of Common Stock as of the close of business on the Distribution Date (other than any Acquiring Person or any Associate or Affiliate of an Acquiring Person), at the address of such holder shown on the records of the Company, a Right
Certificate, in substantially the form of Exhibit A hereto (a “Right Certificate”), evidencing one Right (subject to adjustment as provided herein) for each share of Common Stock so held. As of the Distribution Date, the
Rights will be evidenced solely by such Right Certificates. 
  
 (b)    On the Record Date, or as
soon as practicable thereafter, the Company will send a copy of a Summary of Rights to Purchase Shares of Common Stock, in substantially the form of Exhibit B hereto (the “Summary of Rights”), by first-class, postage-prepaid
mail, to each record holder of Common Stock as of the Close of Business on the Record Date (other than any Acquiring Person or any Associate or Affiliate of any Acquiring Person), at the address of such holder shown on the records of the Company.
With respect to certificates for Common Stock outstanding as of the Record Date, until the Distribution Date, the Rights will be evidenced by such certificates registered in the names of the holders thereof together with the Summary of Rights. Until
the Distribution Date (or, if earlier, the Expiration Date), the surrender for transfer of any certificate for Common Stock outstanding on the Record Date, with or without a copy of the Summary of Rights, shall also constitute the transfer of the
Rights associated with the Common Stock represented thereby. 
  
 (c)    Rights shall be issued in
respect of all shares of Common Stock issued or disposed of (including, without limitation, upon disposition of Common Stock out of treasury stock or issuance or reissuance of Common Stock out of authorized but unissued shares) after the Record Date
but prior to the earlier of the Distribution Date and the Expiration Date, or in certain circumstances provided in Section 22 hereof, after the Distribution Date. Certificates issued for Common Stock (including, without limitation, upon transfer of
outstanding Common Stock, disposition of Common Stock out of treasury stock or issuance or reissuance of Common Stock out of authorized but unissued shares) after the Record Date but prior to the earlier of the Distribution Date and the Expiration
Date, shall have impressed on, printed on, written on or otherwise affixed to them the following legend: 
  
 This
certificate also evidences and entitles the holder hereof to certain rights as set forth in a Rights Agreement between DaVita Inc. (the “Company”) and The Bank of New York, as Rights Agent, dated as of November 14, 2002 and as amended from
time to time (the “Rights Agreement”), the terms of which are hereby incorporated herein by reference and a copy of which is on file at the principal executive offices of the Company. Under certain circumstances, as set forth in

 
 -6- 

 the Rights Agreement, such Rights will be evidenced by separate certificates and will no longer be evidenced by this
certificate. The Company will mail to the holder of this certificate a copy of the Rights Agreement without charge after receipt of a written request therefor. Under certain circumstances, as set forth in the Rights Agreement, Rights owned by or
transferred to any Person who is or becomes an Acquiring Person (as defined in the Rights Agreement) and certain transferees thereof will become null and void and will no longer be transferable. 
  
 With respect to such certificates containing the foregoing legend, until the Distribution Date the Rights associated with the Common Stock represented by such
certificates shall be evidenced by such certificates alone, and the surrender for transfer of any such certificate, except as otherwise provided herein, shall also constitute the transfer of the Rights associated with the Common Stock represented
thereby. In the event that the Company purchases or otherwise acquires any Common Stock after the Record Date but prior to the Distribution Date, any Rights associated with such Common Stock shall be deemed canceled and retired so that the Company
shall not be entitled to exercise any Rights associated with the Common Stock which are no longer outstanding. 
  
 Notwithstanding this paragraph (c), the omission of a legend shall not affect the enforceability of any part of this Agreement or the rights of any holder of the Rights. 
  
 Section 4.  Form of Right Certificates.  The Right Certificates (and the forms of election to purchase shares and of assignment to be printed on
the reverse thereof) shall be substantially in the form set forth in Exhibit A hereto and may have such marks of identification or designation and such legends, summaries or endorsements printed thereon as the Company may deem
appropriate and as are not inconsistent with the provisions of this Agreement, or as may be required to comply with any applicable law or with any rule or regulation made pursuant thereto or with any rule or regulation of any stock exchange or
interdealer quotation system on which the Rights may from time to time be listed or quoted, or to conform to usage. Subject to the provisions of this Agreement, the Right Certificates shall entitle the holders thereof to purchase such number of
shares of Common Stock as shall be set forth therein at the Purchase Price, but the number of such shares of Common Stock and the Purchase Price shall be subject to adjustment as provided herein. 
  

Section 5.  Countersignature and Registration. 
  
 (a)    The Right Certificates shall be executed on behalf of the Company by the Chairman of the Board or any Vice President of the Company, either manually or by facsimile
signature, shall have affixed thereto the Company’s seal or a facsimile thereof and shall be attested by the Secretary of the Company, either manually or by facsimile signature. The Right Certificates shall be manually countersigned by the
Rights Agent and shall not be valid for any purpose unless countersigned. In case any officer of the Company who shall have signed any of the Right Certificates shall cease to be such officer of the Company before countersignature 

 
 -7- 

 by the Rights Agent and issuance and delivery by the Company, such Right Certificates, nevertheless, may be countersigned by the Rights Agent
and issued and delivered by the Company with the same force and effect as though the Person who signed such Right Certificates had not ceased to be such officer of the Company; and any Right Certificate may be signed on behalf of the Company by any
Person who, at the actual date of the execution of such Right Certificate, shall be a proper officer of the Company to sign such Right Certificate, although at the date of the execution of this Agreement any such Person was not such an officer.

  
 (b)    Following the Distribution Date, the Rights Agent will keep or cause to be kept, at an
office or agency designated for such purpose, books for registration and transfer of the Right Certificates issued hereunder. Such books shall show the names and addresses of the respective holders of the Right Certificates, the number of Rights
evidenced on its face by each of the Right Certificates and the date of each of the Right Certificates. 
  
 Section
6.  Transfer, Split Up, Combination and Exchange of Right Certificates; Mutilated, Destroyed, Lost or Stolen Right Certificates. 
  
 (a)    Subject to the provisions of this Agreement, at any time after the Distribution Date and prior to the Expiration Date, any Right Certificate or Right Certificates may be
transferred, split up, combined or exchanged for another Right Certificate or Right Certificates, entitling the registered holder to purchase a like number of shares of Common Stock as the Right Certificate or Right Certificates surrendered then
entitled such holder to purchase. Any registered holder desiring to transfer, split up, combine or exchange any Right Certificate or Right Certificates shall make such request in writing delivered to the Rights Agent, and shall surrender the Right
Certificate or Right Certificates to be transferred, split up, combined or exchanged at the office or agency of the Rights Agent designated for such purpose. Thereupon the Rights Agent shall countersign and deliver to the Person entitled thereto a
Right Certificate or Right Certificates, as the case may be, as so requested. The Company may require payment of a sum sufficient to cover any tax or governmental charge that may be imposed in connection with any transfer, split up, combination or
exchange of Right Certificates. 
  
 (b)    Subject to the provisions of this Agreement, at any
time after the Distribution Date and prior to the Expiration Date, upon receipt by the Company and the Rights Agent of evidence reasonably satisfactory to them of the loss, theft, destruction or mutilation of a Right Certificate, and, in case of
loss, theft or destruction, of indemnity or security reasonably satisfactory to them, and, at the Company’s request, reimbursement to the Company and the Rights Agent of all reasonable expenses incidental thereto, and upon surrender to the
Rights Agent and cancellation of the Right Certificate if mutilated, the Company will make and deliver a new Right Certificate of like tenor to the Rights Agent for delivery to the registered holder in lieu of the Right Certificate so lost, stolen,
destroyed or mutilated. 

 
 -8- 

  
 Section 7.  Exercise of Rights, Purchase Price; Expiration Date of
Rights. 
  
 (a)    Except as otherwise provided herein, the Rights shall become exercisable
on the Distribution Date, and thereafter the registered holder of any Right Certificate may, subject to Section 11(a)(i) hereof and except as otherwise provided herein, exercise the Rights evidenced thereby in whole or in part upon surrender of the
Right Certificate, with the form of election to purchase on the reverse side thereof duly executed, to the Rights Agent at the office or agency of the Rights Agent designated for such purpose, together with payment of the aggregate Purchase Price
with respect to the total number of shares of Common Stock (or preferred stock, other securities, cash or other assets, as the case may be) as to which the Rights are exercised, at any time which is both after the Distribution Date and prior to the
time (the “Expiration Date”) that is the earliest of (i) the Close of Business on November 14, 2012 (the “Final Expiration Date”), (ii) the time at which the Rights are redeemed as provided in Section 23 hereof (the
“Redemption Date”) or (iii) the time at which such Rights are exchanged as provided in Section 24 hereof. 
  
 (b)    The Purchase Price shall be initially $125.00 for each share of Common Stock purchasable upon the exercise of a Right. The Purchase Price and the number of shares of Common Stock or preferred stock or other
securities or property to be acquired upon exercise of a Right shall be subject to adjustment from time to time as provided in Sections 11 and 13 hereof and shall be payable in lawful money of the United States of America in accordance with
paragraph (c) of this Section 7. 
  
 (c)    Except as otherwise provided herein, upon receipt of
a Right Certificate representing exercisable Rights, with the form of election to purchase duly executed, accompanied by payment of the aggregate Purchase Price for the shares of Common Stock to be purchased and an amount equal to any applicable
transfer tax required to be paid by the holder of such Right Certificate in accordance with Section 9 hereof, in cash or by certified check, cashier’s check or money order payable to the order of the Company, the Rights Agent shall thereupon
promptly (i) (A) requisition from any transfer agent of the Common Stock, or make available if the Rights Agent is the transfer agent for the Common Stock, certificates for the number of shares of Common Stock to be purchased, and the Company hereby
irrevocably authorizes its transfer agent to comply with all such requests, or (B) requisition from a depositary agent appointed by the Company depositary receipts representing interests in such number of shares of Common Stock as are to be
purchased (in which case certificates for the Common Stock represented by such receipts shall be deposited by the transfer agent with the depositary agent), and the Company hereby directs any such depositary agent to comply with such request, (ii)
when appropriate, requisition from the Company the amount of cash to be paid in lieu of issuance of fractional shares in accordance with Section 14 hereof, (iii) promptly after receipt of such certificates or depositary receipts, cause the same to
be delivered to or upon the order of the registered holder of such Right Certificate, registered in such name or names as may be designated by such holder and (iv) when appropriate, after receipt, promptly deliver such cash to or upon the order of
the registered holder of such Right Certificate. 

 
 -9- 

  
 (d)    Except as otherwise provided herein, in case the
registered holder of any Right Certificate shall exercise less than all of the Rights evidenced thereby, a new Right Certificate evidencing Rights equivalent to the exercisable Rights remaining unexercised shall be issued by the Rights Agent to the
registered holder of such Right Certificate or to his duly authorized assigns, subject to the provisions of Section 14 hereof. 
  
 (e)    Notwithstanding anything in this Agreement to the contrary, neither the Rights Agent nor the Company shall be obligated to undertake any action with respect to a registered holder of Rights upon the
occurrence of any purported transfer or exercise of Rights pursuant to Section 6 hereof or this Section 7 unless such registered holder shall have (i) completed and signed the certificate contained in the form of assignment or form of election to
purchase set forth on the reverse side of the Right Certificate surrendered for such transfer or exercise and (ii) provided such additional evidence of the identity of the Beneficial Owner (or former Beneficial Owner) thereof as the Company shall
reasonably request. 
  
 Section 8.  Cancellation and Destruction of Right
Certificates.  All Right Certificates surrendered for the purpose of exercise, transfer, split up, combination or exchange shall, if surrendered to the Company or to any of its agents, be delivered to the Rights Agent for cancellation
or in canceled form, or, if surrendered to the Rights Agent, shall be canceled by it, and no Right Certificates shall be issued in lieu thereof except as expressly permitted by any of the provisions of this Agreement. The Company shall deliver to
the Rights Agent for cancellation and retirement, and the Rights Agent shall so cancel and retire, any other Right Certificate purchased or acquired by the Company otherwise than upon the exercise thereof. The Rights Agent shall deliver all canceled
Right Certificates to the Company, or shall, at the written request of the Company, destroy such canceled Right Certificates, and in such case shall deliver a certificate of destruction thereof to the Company. 
  
 Section 9.  Availability of Shares of Common Stock. 
  
 (a)    The Company covenants and agrees that, from and after such time as any Person becomes an Acquiring Person, it will cause to be reserved and kept
available out of its authorized and unissued shares of Common Stock or any shares of Common Stock held in its treasury, the number of shares of Common Stock that will be sufficient to permit the exercise in full of all outstanding Rights.

  
 (b)    So long as the shares of Common Stock issuable upon the exercise of Rights may be
listed or admitted to trading on any national securities exchange, or quoted on NASDAQ, the Company shall use its best efforts to cause, from and after such time as the Rights become exercisable, all shares reserved for such issuance to be listed or
admitted to trading on such exchange, or quoted on NASDAQ, upon official notice of issuance upon such exercise. 
  
 (c)    From and after such time as the Rights become exercisable, the Company shall use its best efforts, if then necessary to permit the issuance of shares of Common Stock upon the exercise of Rights, to register
and qualify such shares of Common Stock under the 

 
 -10- 

 Securities Act and any applicable state securities or “Blue Sky” laws (to the extent exemptions therefrom are not available), cause
such registration statement and qualifications to become effective as soon as possible after such filing and keep such registration and qualifications effective (with a prospectus at all times meeting the requirements of the Securities Act) until
the earlier of the date as of which the Rights are no longer exercisable for such securities and the Expiration Date. The Company may temporarily suspend, for a period of time not to exceed 90 days, the exercisability of the Rights in order to
prepare and file a registration statement under the Securities Act and permit it to become effective. Upon any such suspension, the Company shall issue a public announcement stating that the exercisability of the Rights has been temporarily
suspended, as well as a public announcement at such time as the suspension is no longer in effect. Notwithstanding any provision of this Agreement to the contrary, the Rights shall not be exercisable in any jurisdiction unless the requisite
qualification in such jurisdiction shall have been obtained and until a registration statement under the Securities Act shall have been declared effective, unless an exemption therefrom is available. 
  
 (d)    The Company covenants and agrees that it will take all such action as may be necessary to ensure that all
shares of Common Stock delivered upon exercise of Rights shall, at the time of delivery of the certificates therefor (subject to payment of the Purchase Price), be duly and validly authorized and issued and fully paid and nonassessable shares.

  
 (e)    The Company further covenants and agrees that it will pay when due and payable any and
all federal and state transfer taxes and charges which may be payable in respect of the issuance or delivery of the Right Certificates or of any shares of Common Stock upon the exercise of Rights. The Company shall not, however, be required to pay
any transfer tax which may be payable in respect of any transfer or delivery of Right Certificates to a Person other than, or the issuance or delivery of certificates or depositary receipts for the Common Stock in a name other than that of, the
registered holder of the Right Certificate evidencing Rights surrendered for exercise or to issue or deliver any certificates or depositary receipts for Common Stock upon the exercise of any Rights until any such tax shall have been paid (any such
tax being payable by that holder of such Right Certificate at the time of surrender) or until it has been established to the Company’s reasonable satisfaction that no such tax is due. 
  
 Section 10.  Common Stock Record Date. Each Person in whose name any certificate for Common Stock is issued upon the exercise of Rights shall for all
purposes be deemed to have become the holder of record of the shares of Common Stock represented thereby on, and such certificate shall be dated, the date upon which the Right Certificate evidencing such Rights was duly surrendered and payment of
the Purchase Price (and any applicable transfer taxes) was made; provided, however, that if the date of such surrender and payment is a date upon which the Common Stock transfer books of the Company are closed, such Person shall be
deemed to have become the record holder of such shares on, and such certificate shall be dated, the next succeeding Business Day on which the Common Stock transfer books of the Company are open. Prior to the exercise of the Rights evidenced thereby,
the holder of a Right Certificate shall not be entitled to any rights of a holder of Common 

 
 -11- 

 Stock for which the Rights shall be exercisable, including, without limitation, the right to vote or to receive dividends or other
distributions, and shall not be entitled to receive any notice of any proceedings of the Company, except as provided herein. 
  
 Section 11.  Adjustment of Purchase Price, Number and Kind of Shares and Number of Rights.    The Purchase Price, the number of shares of Common Stock or other securities or property purchasable
upon exercise of each Right and the number of Rights outstanding are subject to adjustment from time to time as provided in this Section 11. 
  
 (a)(i)    Subject to Section 24 of this Agreement, in the event any Person becomes an Acquiring Person (the first occurrence of such event being referred to hereinafter as the
“Flip-In Event”), then (A) the Purchase Price shall be adjusted to be the Purchase Price in effect immediately prior to the Flip-In Event multiplied by the number of shares of Common Stock for which a Right was exercisable immediately
prior to such Flip-In Event, whether or not such Right was then exercisable, and (B) each holder of a Right, except as otherwise provided in this Section 11(a)(i) and Section 11(a)(ii) hereof, shall thereafter have the right to receive, upon
exercise thereof at a price equal to the Purchase Price (as so adjusted), in accordance with the terms of this Agreement such number of shares of Common Stock as shall equal the result obtained by dividing the Purchase Price (as so adjusted) by 50%
of the current per share market price of the Common Stock (determined pursuant to Section 11(d) hereof) on the date of such Flip-In Event; provided, however, that the Purchase Price (as so adjusted) and the number of shares of Common
Stock so receivable upon exercise of a Right shall, following the Flip-In Event, be subject to further adjustment as appropriate in accordance with Section 11(f) hereof. Notwithstanding anything in this Agreement to the contrary, however, from and
after the Flip-In Event, any Rights that are beneficially owned by (x) any Acquiring Person (or any Affiliate or Associate of any Acquiring Person), (y) a transferee of any Acquiring Person (or any such Affiliate or Associate) who becomes a
transferee after the Flip-In Event, or (z) a transferee of any Acquiring Person (or any such Affiliate or Associate) who became a transferee prior to or concurrently with the Flip-In Event pursuant to either (I) a transfer from the Acquiring Person
to holders of its equity securities or to any Person with whom it has any continuing agreement, arrangement or understanding regarding the transferred Rights, or (II) a transfer which the Board of Directors of the Company has determined is part of a
plan, arrangement or understanding which has the purpose or effect of avoiding the provisions of this paragraph, and subsequent transferees of such Persons, shall be void without any further action and any holder of such Rights shall thereafter have
no rights whatsoever with respect to such Rights under any provision of this Agreement. The Company shall use all reasonable efforts to ensure that the provisions of this Section 11(a)(i) are complied with, but shall have no liability to any holder
of Right Certificates or other Person as a result of its failure to make any determinations with respect to an Acquiring Person or its Affiliates, Associates or transferees hereunder. From and after the Flip-In Event, no Right Certificate shall be
issued pursuant to Section 3 or Section 6 hereof that represents Rights that are or have become void pursuant to the provisions of this paragraph, and any Right Certificate delivered to the Rights Agent that represents Rights that are or have become
void pursuant to the provisions of this paragraph shall be canceled. From and after the occurrence of an event specified in Section 13(a) hereof, any Rights that theretofore have not been exercised pursuant 

 
 -12- 

 to this Section 11(a)(i) shall thereafter be exercisable only in accordance with Section 13 and not pursuant to this Section 11(a)(i).

  
 (ii)    In the event that there shall not be sufficient shares of Common Stock issued but not
outstanding or authorized but unissued to permit the exercise in full of the Rights in accordance with the foregoing subparagraph (i), the Board of Directors of the Company shall, with respect to such deficiency, to the extent permitted by
applicable law and any material agreements then in effect to which the Company is a party (A) determine the excess (such excess, the “Spread”) of (1) the value of the shares of Common Stock issuable upon the exercise of a Right in
accordance with the foregoing subparagraph (i) (the “Current Value”) over (2) the Purchase Price (as adjusted in accordance with the foregoing subparagraph (i)), and (B) with respect to each Right (other than Rights which have become void
pursuant to the foregoing subparagraph (i)), make adequate provision to substitute for the shares of Common Stock issuable in accordance with the foregoing subparagraph (i) upon exercise of the Right and payment of the Purchase Price (as adjusted in
accordance therewith), (1) cash, (2) a reduction in such Purchase Price, (3) shares of preferred stock or other equity securities of the Company (including, without limitation, shares of preferred stock or equity securities which, by virtue of
having rights substantially comparable to those of the shares of Common Stock, are deemed in good faith by the Board of Directors of the Company to have substantially the same value as the shares of Common Stock (such shares of preferred stock or
other equity securities are hereinafter referred to as “Common Stock Equivalents”)), (4) debt securities of the Company, (5) other assets, or (6) any combination of the foregoing, having a value which, when added to the value of the shares
of Common Stock issued upon exercise of such Right, shall have an aggregate value equal to the Current Value (less the amount of any reduction in such Purchase Price), where such aggregate value has been determined by the Board of Directors of the
Company upon the advice of a nationally recognized investment banking firm selected in good faith by the Board of Directors of the Company; provided, however, that if the Company shall not make adequate provision to deliver value
pursuant to clause (B) above within thirty (30) days following the Flip-In Event (the date of the Flip-In-Event being a “Section 11(a)(i) Trigger Date”), then the Company shall be obligated to deliver, to the extent permitted by applicable
law and any material agreements then in effect to which the Company is a party, upon the surrender for exercise of a Right and without requiring payment of such Purchase Price, shares of Common Stock (to the extent available), and then, if
necessary, such number of shares of preferred stock or other equity securities (to the extent available), and then, if necessary, cash, which shares and/or cash have an aggregate value equal to the Spread. If, upon the occurrence of the Flip-In
Event, the Board of Directors of the Company shall determine in good faith that it is likely that sufficient additional shares of Common Stock could be authorized for issuance upon exercise in full of the Rights, then, if the Board of Directors of
the Company so elects, the thirty (30) day period set forth above may be extended to the extent necessary, but not more than ninety (90) days after the Section 11(a)(i) Trigger Date, in order that the Company may seek stockholder approval for the
authorization of such additional shares (such thirty (30) day period, as it may be extended, is herein called the “Substitution Period”). To the extent that the Company determines that some action need be taken pursuant to the first and/or
second sentence of this Section 11(a)(ii), the Company (x) shall provide, subject to Section 11(a)(i) hereof and the last 

 
 -13- 

 sentence of this Section 11(a)(ii) hereof, that such action shall apply uniformly to all outstanding Rights and (y) may suspend the
exercisability of the Rights until the expiration of the Substitution Period in order to seek any authorization of additional shares and/or to decide the appropriate form of distribution to be made pursuant to such second sentence and to determine
the value thereof. In the event of any such suspension, the Company shall issue a public announcement stating that the exercisability of the Rights has been temporarily suspended, as well as a public announcement at such time as the suspension is no
longer in effect. For purposes of this Section 11(a)(ii), the value of the shares of Common Stock shall be the current per share market price (as determined pursuant to Section 11(d)(i)) on the Section 11(a)(i) Trigger Date and the per share or
fractional value of any “Common Stock Equivalent” shall be deemed to equal the current per share market price of the Common Stock. The Board of Directors of the Company may, but shall not be required to, establish procedures to allocate
the right to receive shares of Common Stock upon the exercise of the Rights among holders of Rights pursuant to this Section 11(a)(ii). 
  
 (b)    In case the Company shall fix a record date for the issuance of rights, options or warrants to all holders of Common Stock entitling them (for a period expiring within 45 calendar days after such
record date) to subscribe for or purchase Common Stock (or shares having the same rights, privileges and preferences as the Common Stock (“Equivalent Common Shares”)) or securities convertible into Common Stock or Equivalent Common Shares
at a price per share of Common Stock or Equivalent Common Shares (or having a conversion price per share, if a security convertible into shares of Common Stock or Equivalent Common Shares) less than the then current per share market price of the
Common Stock (determined pursuant to Section 11(d) hereof) on such record date, the Purchase Price to be in effect after such record date shall be determined by multiplying the Purchase Price in effect immediately prior to such record date by a
fraction, the numerator of which shall be the number of shares of Common Stock and Equivalent Common Shares outstanding on such record date plus the number of shares of Common Stock and Equivalent Common Shares which the aggregate offering price of
the total number of shares of Common Stock and/or Equivalent Common Shares so to be offered (and/or the aggregate initial conversion price of the convertible securities so to be offered) would purchase at such current market price, and the
denominator of which shall be the number of shares of Common Stock and Equivalent Common Shares outstanding on such record date plus the number of additional shares of Common Stock and/or Equivalent Common Shares to be offered for subscription or
purchase (or into which the convertible securities so to be offered are initially convertible); provided, however, that in no event shall the consideration to be paid upon the exercise of one Right be less than the aggregate par value
of the shares of capital stock of the Company issuable upon exercise of one Right. In case such subscription price may be paid in a consideration part or all of which shall be in a form other than cash, the value of such consideration shall be as
determined in good faith by the Board of Directors of the Company, whose determination shall be described in a statement filed with the Rights Agent. Shares of Common Stock and Equivalent Common Shares owned by or held for the account of the Company
shall not be deemed outstanding for the purpose of any such computation. Such adjustment shall be made successively whenever such a record date is fixed; and in the event that such rights, options 

 
 -14- 

 or warrants are not so issued, the Purchase Price shall be adjusted to be the Purchase Price which would then be in effect if such record date
had not been fixed. 
  
 (c)    In case the Company shall fix a record date for the making of a
distribution to all holders of the Common Stock (including any such distribution made in connection with a consolidation or merger in which the Company is the continuing or surviving corporation) of evidences of indebtedness or assets (other than a
regular cash dividend or a dividend payable in Common Stock) or subscription rights or warrants (excluding those referred to in Section 11(b) hereof), the Purchase Price to be in effect after such record date shall be determined by multiplying the
Purchase Price in effect immediately prior to such record date by a fraction, the numerator of which shall be the then current per share market price of the Common Stock (determined pursuant to Section 11(d) hereof) on such record date, less the
fair market value (as determined in good faith by the Board of Directors of the Company whose determination shall be described in a statement filed with the Rights Agent) of the portion of the assets or evidences of indebtedness so to be distributed
or of such subscription rights or warrants applicable to one share of Common Stock, and the denominator of which shall be such current per share market price (determined pursuant to Section 11(d) hereof) of the Common Stock; provided,
however, that in no event shall the consideration to be paid upon the exercise of one Right be less than the aggregate par value of the shares of capital stock of the Company to be issued upon exercise of one Right. Such adjustments shall be
made successively whenever such a record date is fixed; and in the event that such distribution is not so made, the Purchase Price shall again be adjusted to be the Purchase Price which would then be in effect if such record date had not been fixed.

  
 (d)(i)  Except as otherwise provided herein, for the purpose of any computation hereunder, the
“current per share market price” of any security (a “Security” for the purpose of this Section 11(d)(i)) on any date shall be deemed to be the average of the daily closing prices per share of such Security for the 30 consecutive
Trading Days (as such term is hereinafter defined) immediately prior to such date; provided, however, that in the event that the current per share market price of the Security is determined during a period following the announcement by
the issuer of such Security of (A) a dividend or distribution on such Security payable in shares of such Security or securities convertible into such shares, or (B) any subdivision, combination or reclassification of such Security, and prior to the
expiration of 30 Trading Days after the ex-dividend date for such dividend or distribution, or the record date for such subdivision, combination or reclassification, then, and in each such case, the current per share market price shall be
appropriately adjusted to reflect the current market price per share equivalent of such Security. The closing price for each day shall be the last sale price, regular way, or, in case no such sale takes place on such day, the average of the closing
bid and asked prices, regular way, in either case as reported by the principal consolidated transaction reporting system with respect to securities listed or admitted to trading on the New York Stock Exchange or, if the Security is not listed or
admitted to trading on the New York Stock Exchange, as reported in the principal consolidated transaction reporting system with respect to securities listed on the principal national securities exchange on which the Security is listed or admitted to
trading or, if the Security is not listed or admitted to trading on any national securities exchange, the last quoted price or, if not so quoted, the average of the high bid and 

 
 -15- 

 low asked prices in the over-the-counter market, as reported by NASDAQ or such other system then in use, or, if on any such date the Security is
not quoted by any such organization, the average of the closing bid and asked prices as furnished by a professional market maker making a market in the Security selected by the Board of Directors of the Company. The term “Trading Day”
shall mean a day on which the principal national securities exchange on which the Security is listed or admitted to trading is open for the transaction of business or, if the Security is not listed or admitted to trading on any national securities
exchange, a Business Day. 
  
 (ii)    For the purpose of any computation hereunder, if the Common
Stock is publicly traded, the “current per share market price” of the Common Stock shall be determined in accordance with the method set forth in Section 11(d)(i). If the Common Stock is not publicly traded, “current per share market
price” shall mean the fair value per share as determined in good faith by the Board of Directors of the Company, whose determination shall be described in a statement filed with the Rights Agent. 
  
 (e)    No adjustment in the Purchase Price shall be required unless such adjustment would require an increase or
decrease of at least 1% in the Purchase Price; provided, however, that any adjustments which by reason of this Section 11(e) are not required to be made shall be carried forward and taken into account in any subsequent adjustment. All
calculations under this Section 11 shall be made to the nearest cent or to the nearest ten-thousandth of a share of Common Stock or other share or security, as the case may be. Notwithstanding the first sentence of this Section 11(e), any adjustment
required by this Section 11 shall be made no later than the earlier of (i) three years from the date of the transaction which requires such adjustment or (ii) the Expiration Date. 
  
 (f)    If as a result of an adjustment made pursuant to this Agreement, the holder of any Right thereafter exercised shall become entitled to receive
any shares of capital stock of the Company other than the Common Stock, thereafter the Purchase Price and the number of such other shares so receivable upon exercise of a Right shall be subject to adjustment from time to time in a manner and on
terms as nearly equivalent as practicable to the provisions with respect to the Common Stock contained in Sections 11(a), 11(b), 11(c), 11(e), 11(h), 11(i) and 11(m) hereof, as applicable, and the provisions of Sections 7, 9, 10, 13 and 14 hereof
with respect to the Common Stock shall apply on like terms to any such other shares. 
  
 (g)    All Rights originally issued by the Company subsequent to any adjustment made to the Purchase Price hereunder shall evidence the right to purchase, at the adjusted Purchase Price, the number of shares of
Common Stock purchasable from time to time hereunder upon exercise of the Rights, all subject to further adjustment as provided herein. 
  
 (h)    Unless the Company shall have exercised its election as provided in Section 11(i), upon each adjustment of the Purchase Price as a result of the calculations made in Sections 11(b) and 11(c), each
Right outstanding immediately prior to the making of such adjustment shall thereafter evidence the right to purchase, at the adjusted Purchase Price, that number of shares of Common Stock (calculated to the nearest ten-thousandth of a share of

 
 -16- 

 Common Stock) obtained by (i) multiplying (x) the number of shares of Common Stock purchasable upon the exercise of a Right immediately prior to
such adjustment by (y) the Purchase Price in effect immediately prior to such adjustment and (ii) dividing the product so obtained by the Purchase Price in effect immediately after such adjustment. 
  
 (i)    The Company may elect on or after the date of any adjustment of the Purchase Price pursuant to Sections 11(b)
or 11(c) hereof to adjust the number of Rights, in substitution for any adjustment in the number of shares of Common Stock purchasable upon the exercise of a Right. Each of the Rights outstanding after such adjustment of the number of Rights shall
be exercisable for the number of shares of Common Stock for which a Right was exercisable immediately prior to such adjustment. Each Right held of record prior to such adjustment of the number of Rights shall become that number of Rights (calculated
to the nearest ten-thousandth) obtained by dividing the Purchase Price in effect immediately prior to adjustment of the Purchase Price by the Purchase Price in effect immediately after adjustment of the Purchase Price. The Company shall make a
public announcement of its election to adjust the number of Rights, indicating the record date for the adjustment, and, if known at the time, the amount of the adjustment to be made. Such record date may be the date on which the Purchase Price is
adjusted or any day thereafter, but, if the Right Certificates have been issued, shall be at least 10 days later than the date of the public announcement. If Right Certificates have been issued, upon each adjustment of the number of Rights pursuant
to this Section 11(i), the Company may, as promptly as practicable, cause to be distributed to holders of record of Right Certificates on such record date Right Certificates evidencing, subject to Section 14 hereof, the additional Rights to which
such holders shall be entitled as a result of such adjustment, or, at the option of the Company, shall cause to be distributed to such holders of record in substitution and replacement for the Right Certificates held by such holders prior to the
date of adjustment, and upon surrender thereof, if required by the Company, new Right Certificates evidencing all the Rights to which such holders shall be entitled after such adjustment. Right Certificates so to be distributed shall be issued,
executed and countersigned in the manner provided for herein and shall be registered in the names of the holders of record of Right Certificates on the record date specified in the public announcement. 
  
 (j)    Irrespective of any adjustment or change in the Purchase Price or the number of shares of Common Stock issuable
upon the exercise of a Right, the Right Certificates theretofore and thereafter issued may continue to express the Purchase Price and the number of shares of Common Stock which were expressed in the initial Right Certificates issued hereunder.

  
 (k)    Before taking any action that would cause an adjustment reducing the Purchase Price
below the then par value, if any, of the shares of Common Stock or other shares of capital stock issuable upon exercise of a Right, the Company shall take any corporate action which may, in the opinion of its counsel, be necessary in order that the
Company may validly and legally issue fully paid and nonassessable shares of Common Stock or other such shares at such adjusted Purchase Price. 
  

 
 -17- 

  
 (l)    In any case in which this Section 11 shall require
that an adjustment in the Purchase Price be made effective as of a record date for a specified event, the Company may elect to defer until the occurrence of such event issuing to the holder of any Right exercised after such record date the Common
Stock and other capital stock or securities of the Company, if any, issuable upon such exercise over and above the Common Stock and other capital stock or securities of the Company, if any, issuable upon such exercise on the basis of the Purchase
Price in effect prior to such adjustment; provided, however, that the Company shall deliver to such holder a due bill or other appropriate instrument evidencing such holder’s right to receive such additional shares upon the
occurrence of the event requiring such adjustment. 
  
 (m)    Anything in this Section 11 to the
contrary notwithstanding, the Company shall be entitled to make such adjustments in the Purchase Price, in addition to those adjustments expressly required by this Section 11, as and to the extent that it in its sole discretion shall determine to be
advisable in order that any consolidation or subdivision of the Common Stock, issuance wholly for cash of any shares of Common Stock at less than the current market price, issuance wholly for cash of Common Stock or securities which by their terms
are convertible into or exchangeable for Common Stock, dividends on Common Stock payable in shares of Common Stock or issuance of rights, options or warrants referred to herein above in Section 11(b), hereafter made by the Company to holders of its
Common Stock shall not be taxable to such stockholders. 
  
 (n)    Anything in this Agreement to
the contrary notwithstanding, in the event that at any time after the date of this Agreement and prior to the Distribution Date, the Company shall (i) declare and pay any dividend on the Common Stock payable in Common Stock or (ii) effect a
subdivision, combination or consolidation of the Common Stock (by reclassification or otherwise than by payment of a dividend payable in Common Stock) into a greater or lesser number of shares of Common Stock, then, in each such case, the number of
Rights associated with each share of Common Stock then outstanding, or issued or delivered thereafter, shall be proportionately adjusted so that the number of Rights thereafter associated with each share of Common Stock following any such event
shall equal the result obtained by multiplying the number of Rights associated with each share of Common Stock immediately prior to such event by a fraction the numerator of which shall be the total number of shares of Common Stock outstanding
immediately prior to the occurrence of the event and the denominator of which shall be the total number of shares of Common Stock outstanding immediately following the occurrence of such event. 
  

(o)    The Company agrees that, after the earlier of the Distribution Date or the Stock Acquisition Date, it will not, except as permitted by
Sections 23, 24 or 27 hereof, take (or permit any Subsidiary to take) any action if at the time such action is taken it is reasonably foreseeable that such action will diminish substantially or eliminate the benefits intended to be afforded by the
Rights. 
  
 Section 12.  Certificate of Adjusted Purchase Price or Number of
Shares.  Whenever an adjustment is made as provided in Section 11 or 13 hereof, the Company shall promptly (a) prepare a certificate setting forth such adjustment, and a brief statement of the 

 
 -18- 

 facts accounting for such adjustment, (b) file with the Rights Agent and with each transfer agent for the Common Stock a copy of such
certificate and (c) mail a brief summary thereof to each holder of a Right Certificate in accordance with Section 25 hereof (if so required under Section 25 hereof). The Rights Agent shall be fully protected in relying on any such certificate and on
any adjustment therein contained and shall not be deemed to have knowledge of any such adjustment unless and until it shall have received such certificate. 
  
 Section 13.  Consolidation, Merger or Sale or Transfer of Assets or Earning Power. 
  
 (a)    In the event, directly or indirectly, at any time after the Flip-In Event (i) the Company shall consolidate with or shall merge into any other Person, (ii) any Person shall
merge with and into the Company and the Company shall be the continuing or surviving corporation of such merger and, in connection with such merger, all or part of the Common Stock shall be changed into or exchanged for stock or other securities of
any other Person (or of the Company) or cash or any other property, or (iii) the Company shall sell or otherwise transfer (or one or more of its Subsidiaries shall sell or otherwise transfer), in one or more transactions, assets or earning power
aggregating 50% or more of the assets or earning power of the Company and its Subsidiaries (taken as a whole) to any other Person (other than the Company or one or more wholly-owned Subsidiaries of the Company), then upon the first occurrence of
such event, proper provision shall be made so that: (A) each holder of a Right (other than Rights which have become void pursuant to Section 11(a)(i) hereof) shall thereafter have the right to receive, upon the exercise thereof at the Purchase Price
(as theretofore adjusted in accordance with Section 11(a)(i) hereof), in accordance with the terms of this Agreement and in lieu of shares of Common Stock of the Company, such number of validly authorized and issued, fully paid, non-assessable and
freely tradeable shares of Common Stock of the Principal Party (as such term is hereinafter defined), not subject to any liens, encumbrances, rights of first refusal or other adverse claims, as shall equal the result obtained by dividing the
Purchase Price (as theretofore adjusted in accordance with Section 11(a)(i) hereof) by 50% of the current per share market price of the Common Stock of such Principal Party (determined pursuant to Section 11(d) hereof) on the date of consummation of
such consolidation, merger, sale or transfer; provided, however, that the Purchase Price (as theretofore adjusted in accordance with Section 11(a)(i) hereof) and the number of shares of Common Stock of such Principal Party so
receivable upon exercise of a Right shall be subject to further adjustment as appropriate in accordance with Section 11(f) hereof to reflect any events occurring in respect of the Common Stock of such Principal Party after the occurrence of such
consolidation, merger, sale or transfer; (B) such Principal Party shall thereafter be liable for, and shall assume, by virtue of such consolidation, merger, sale or transfer, all the obligations and duties of the Company pursuant to this Agreement;
(C) the term “Company” shall thereafter be deemed to refer to such Principal Party; and (D) such Principal Party shall take such steps (including, but not limited to, the reservation of a sufficient number of its shares of Common Stock in
accordance with Section 9 hereof) in connection with such consummation of any such transaction as may be necessary to assure that the provisions hereof shall thereafter be applicable, as nearly as reasonably may be, in relation to the shares of its
Common Stock thereafter deliverable upon the exercise of the Rights; provided that, upon the 

 
 -19- 

 subsequent occurrence of any consolidation, merger, sale or transfer of assets or other extraordinary transaction in respect of such Principal
Party, each holder of a Right shall thereupon be entitled to receive, upon exercise of a Right and payment of the Purchase Price as provided in this Section 13(a), such cash, shares, rights, warrants and other property which such holder would have
been entitled to receive had such holder, at the time of such transaction, owned the Common Stock of the Principal Party receivable upon the exercise of a Right pursuant to this Section 13(a), and such Principal Party shall take such steps
(including, but not limited to, reservation of shares of stock) as may be necessary to permit the subsequent exercise of the Rights in accordance with the terms hereof for such cash, shares, rights, warrants and other property. 

 
 (b)    “Principal Party” shall mean: 
  
 (i)    in the case of any transaction described in (i) or (ii) of the first sentence of Section 13(a) hereof: (A) the Person that is the issuer of the
securities into which the shares of Common Stock are converted in such merger or consolidation, or, if there is more than one such issuer, the issuer the shares of Common Stock of which have the greatest aggregate market value of shares outstanding,
or (B) if no securities are so issued, (x) the Person that is the other party to the merger, if such Person survives said merger, or, if there is more than one such Person, the Person the shares of Common Stock of which have the greatest aggregate
market value of shares outstanding or (y) if the Person that is the other party to the merger does not survive the merger, the Person that does survive the merger (including the Company if it survives) or (z) the Person resulting from the
consolidation; and 
  
 (ii)    in the case of any transaction described in (iii) of the first
sentence of Section 13(a) hereof, the Person that is the party receiving the greatest portion of the assets or earning power transferred pursuant to such transaction or transactions, or, if each Person that is a party to such transaction or
transactions receives the same portion of the assets or earning power so transferred or if the Person receiving the greatest portion of the assets or earning power cannot be determined, whichever of such Persons is the issuer of Common Stock having
the greatest aggregate market value of shares outstanding; 
  
 provided, however, that in any such case described in the foregoing clause
(b)(i) or (b)(ii), if the Common Stock of such Person is not at such time or has not been continuously over the preceding 12-month period registered under Section 12 of the Exchange Act, then (1) if such Person is a direct or indirect Subsidiary of
another Person the Common Stock of which is and has been so registered, the term “Principal Party” shall refer to such other Person, or (2) if such Person is a Subsidiary, directly or indirectly, of more than one Person, the Common Stock
of all of which is and has been so registered, the term “Principal Party” shall refer to whichever of such Persons is the issuer of Common Stock having the greatest aggregate market value of shares outstanding, or (3) if such Person is
owned, directly or indirectly, by a joint venture formed by two or more Persons that are not owned, directly or indirectly, by the same Person, the rules set forth in clauses (1) and (2) above shall apply to each of the owners having an interest in
the venture as if the Person owned by the joint venture was a Subsidiary of both or all of such joint venturers, and the Principal Party in each such case shall bear the obligations 

 
 -20- 

 set forth in this Section 13 in the same ratio as its interest in such Person bears to the total of such interests. 
  
 (c)    The Company shall not consummate any consolidation, merger, sale or transfer referred to in Section 13(a)
hereof unless prior thereto the Company and the Principal Party involved therein shall have executed and delivered to the Rights Agent an agreement confirming that the requirements of Sections 13(a) and (b) hereof shall promptly be performed in
accordance with their terms and that such consolidation, merger, sale or transfer of assets shall not result in a default by the Principal Party under this Agreement as the same shall have been assumed by the Principal Party pursuant to Sections
13(a) and (b) hereof and providing that, as soon as practicable after executing such agreement pursuant to this Section 13, the Principal Party will: 
  
                 (i)    prepare and file a registration statement under the Securities Act, if
necessary, with respect to the Rights and the securities purchasable upon exercise of the Rights on an appropriate form, use its best efforts to cause such registration statement to become effective as soon as practicable after such filing and use
its best efforts to cause such registration statement to remain effective (with a prospectus at all times meeting the requirements of the Securities Act) until the Expiration Date and similarly comply with applicable state securities laws;

  
                 (ii)    use its best efforts, if the Common Stock of the Principal Party shall be listed or admitted to trading on
the New York Stock Exchange or on another national securities exchange, to list or admit to trading (or continue the listing of) the Rights and the securities purchasable upon exercise of the Rights on the New York Stock Exchange or such securities
exchange, or, if the Common Stock of the Principal Party shall not be listed or admitted to trading on the New York Stock Exchange or a national securities exchange, to cause the Rights and the securities receivable upon exercise of the Rights to be
authorized for quotation on NASDAQ or on such other system then in use; 
  
                 (iii)    deliver to holders of the Rights historical financial statements for the Principal Party which comply in all
respects with the requirements for registration on Form 10 (or any successor form) under the Exchange Act; and 
  
                 (iv)    obtain waivers of any rights of first refusal or preemptive rights in respect of the Common Stock of the
Principal Party subject to purchase upon exercise of outstanding Rights. 
  
 (d)    In case the
Principal Party has a provision in any of its authorized securities or in its certificate of incorporation or by-laws or other instrument governing its affairs, which provision would have the effect of (i) causing such Principal Party to issue
(other than to holders of Rights pursuant to this Section 13), in connection with, or as a consequence of, the consummation of a transaction referred to in this Section 13, shares of Common Stock or Common Stock Equivalents of such Principal Party
at less than the then current market price per share thereof (determined pursuant to Section 11(d) hereof) or securities exercisable for, 

 
 -21- 

 or convertible into, Common Stock or Common Stock Equivalents of such Principal Party at less than such then current market price, or (ii)
providing for any special payment, tax or similar provision in connection with the issuance of the Common Stock of such Principal Party pursuant to the provisions of Section 13, then, in such event, the Company hereby agrees with each holder of
Rights that it shall not consummate any such transaction unless prior thereto the Company and such Principal Party shall have executed and delivered to the Rights Agent a supplemental agreement providing that the provision in question of such
Principal Party shall have been canceled, waived or amended, or that the authorized securities shall be redeemed, so that the applicable provision will have no effect in connection with, or as a consequence of, the consummation of the proposed
transaction. 
  
 (e)    The Company covenants and agrees that it shall not, at any time after the
Flip-In Event, enter into any transaction of the type described in clauses (i) through (iii) of Section 13(a) hereof if (i) at the time of or immediately after such consolidation, merger, sale, transfer or other transaction there are any rights,
warrants or other instruments or securities outstanding or agreements in effect which would substantially diminish or otherwise eliminate the benefits intended to be afforded by the Rights, (ii) prior to, simultaneously with or immediately after
such consolidation, merger, sale, transfer or other transaction, the stockholders of the Person who constitutes, or would constitute, the Principal Party for purposes of Section 13(b) hereof shall have received a distribution of Rights previously
owned by such Person or any of its Affiliates or Associates or (iii) the form or nature of organization of the Principal Party would preclude or limit the exercisability of the Rights. 
  
 Section 14.  Fractional Rights and Fractional Shares. 
  
 (a)    The Company shall not be required to issue fractions of Rights (except prior to the Distribution Date in accordance with Section 11(n) hereof) or to distribute Right
Certificates which evidence fractional Rights. In lieu of such fractional Rights, there shall be paid to the registered holders of the Right Certificates with regard to which such fractional Rights would otherwise be issuable, an amount in cash
equal to the same fraction of the current market value of a whole Right. For the purposes of this Section 14(a), the current market value of a whole Right shall be the closing price of the Rights for the Trading Day immediately prior to the date on
which such fractional Rights would have been otherwise issuable. The closing price for any day shall be the last sale price, regular way, or, in case no such sale takes place on such day, the average of the closing bid and asked prices, regular way,
in either case as reported in the principal consolidated transaction reporting system with respect to securities listed or admitted to trading on the New York Stock Exchange or, if the Rights are not listed or admitted to trading on the New York
Stock Exchange, as reported in the principal consolidated transaction reporting system with respect to securities listed on the principal national securities exchange on which the Rights are listed or admitted to trading or, if the Rights are not
listed or admitted to trading on any national securities exchange, the last quoted price or, if not so quoted, the average of the high bid and low asked prices in the over-the-counter market, as reported by NASDAQ or such other system then in use
or, if on any such date the Rights are not quoted by any such organization, the average of the closing bid and asked prices as furnished by a professional market maker making a market in the Rights 

 
 -22- 

 selected by the Board of Directors of the Company. If on any such date no such market maker is making a market in the Rights, the fair value of
the Rights on such date as determined in good faith by the Board of Directors of the Company shall be used. 
  
 (b)    The Company shall not be required to issue fractions of shares of Common Stock or to distribute certificates which evidence fractional shares of Common Stock upon the exercise or exchange of Rights. In lieu
of such fractional shares of Common Stock, the Company shall pay to the registered holders of the Right Certificates with regard to which such fractional shares of Common Stock would otherwise be issuable an amount in cash equal to the same fraction
of the current market value of a whole share of Common Stock (as determined in accordance with Section 14(a) hereof) for the Trading Day immediately prior to the date of such exercise or exchange. 
  
 (c)    The holder of a Right by the acceptance of the Right expressly waives his right to receive any fractional
Rights or any fractional shares upon exercise or exchange of a Right (except as provided above). 
  
 Section
15.  Rights of Action.  All rights of action in respect of this Agreement, excepting the rights of action given to the Rights Agent under Section 18 hereof, are vested in the respective registered holders of the Right
Certificates (and, prior to the Distribution Date, the registered holders of the Common Stock); and any registered holder of any Right Certificate (or, prior to the Distribution Date, of the Common Stock), without the consent of the Rights Agent or
of the holder of any other Right Certificate (or, prior to the Distribution Date, of the Common Stock), on his own behalf and for his own benefit, may enforce, and may institute and maintain any suit, action or proceeding against the Company to
enforce, or otherwise act in respect of, his right to exercise the Rights evidenced by such Right Certificate (or, prior to the Distribution Date, such Common Stock) in the manner provided therein and in this Agreement. Without limiting the
foregoing or any remedies available to the holders of Rights, it is specifically acknowledged that the holders of Rights would not have an adequate remedy at law for any breach of this Agreement and will be entitled to specific performance of the
obligations under, and injunctive relief against actual or threatened violations of, the obligations of any Person subject to this Agreement. 
  
 Section 16.  Agreement of Right Holders.  Every holder of a Right, by accepting the same, consents and agrees with the Company and the Rights Agent and with every other
holder of a Right that: 
  
 (a)    prior to the Distribution Date, the Rights will be
transferable only in connection with the transfer of the Common Stock; 
  
 (b)    after the
Distribution Date, the Right Certificates are transferable only on the registry books of the Rights Agent if surrendered at the office or agency of the Rights Agent designated for such purpose, duly endorsed or accompanied by a proper instrument of
transfer; and 

 
 -23- 

 (c)    the Company and the Rights Agent may deem and treat the Person in whose name the Right
Certificate (or, prior to the Distribution Date, the Common Stock certificate) is registered as the absolute owner thereof and of the Rights evidenced thereby (notwithstanding any notations of ownership or writing on the Right Certificates or the
Common Stock certificate made by anyone other than the Company or the Rights Agent) for all purposes whatsoever, and neither the Company nor the Rights Agent, subject to Section 7(e) hereof, shall be affected by any notice to the contrary.

  
 Section 17.  Right Certificate Holder Not Deemed a Stockholder.  No holder, as such,
of any Right Certificate shall be entitled to vote, receive dividends or be deemed for any purpose the holder of the Common Stock or any other securities of the Company which may at any time be issuable on the exercise or exchange of the Rights
represented thereby, nor shall anything contained herein or in any Right Certificate be construed to confer upon the holder of any Right Certificate, as such, any of the rights of a stockholder of the Company or any right to vote for the election of
directors or upon any matter submitted to stockholders at any meeting thereof, or to give or withhold consent to any corporate action, or to receive notice of meetings or other actions affecting stockholders (except as provided in this Agreement),
or to receive dividends or subscription rights, or otherwise, until the Rights evidenced by such Right Certificate shall have been exercised or exchanged in accordance with the provisions hereof. 
  

Section 18.  Concerning the Rights Agent. 
  
 (a)    The Company agrees to pay to the Rights Agent reasonable compensation for all services rendered by it hereunder and, from time to time, on demand of the Rights Agent, its
reasonable expenses and counsel fees and other disbursements incurred in the administration and execution of this Agreement and the exercise and performance of its duties hereunder. The Company also agrees to indemnify the Rights Agent for, and to
hold it harmless against, any loss, liability or expense, incurred without gross negligence or willful misconduct on the part of the Rights Agent, for anything done or omitted by the Rights Agent in connection with the acceptance and administration
of this Agreement, including the costs and expenses of defending against any claim of liability arising therefrom, directly or indirectly. 
  
 (b)    The Rights Agent shall be protected and shall incur no liability for, or in respect of any action taken, suffered or omitted by it in connection with, its administration of this Agreement in
reliance upon any Right Certificate or certificate for the Common Stock or for other securities of the Company, instrument of assignment or transfer, power of attorney, endorsement, affidavit, letter, notice, direction, consent, certificate,
statement or other paper or document believed by it to be genuine and to be signed, executed and, where necessary, verified or acknowledged, by the proper Person or Persons, or otherwise upon the advice of counsel as set forth in Section 20 hereof.

  

 
 -24- 

  
 Section 19.  Merger or Consolidation or Change of Name of Rights
Agent. 
  
 (a)    Any corporation into which the Rights Agent or any successor Rights Agent
may be merged or with which it may be consolidated, or any corporation resulting from any merger or consolidation to which the Rights Agent or any successor Rights Agent shall be a party, or any corporation succeeding to the stock transfer or
corporate trust powers of the Rights Agent or any successor Rights Agent, shall be the successor to the Rights Agent under this Agreement without the execution or filing of any paper or any further act on the part of any of the parties hereto;
provided, that such corporation would be eligible for appointment as a successor Rights Agent under the provisions of Section 21 hereof. In case at the time such successor Rights Agent shall succeed to the agency created by this Agreement,
any of the Right Certificates shall have been countersigned but not delivered, any such successor Rights Agent may adopt the countersignature of the predecessor Rights Agent and deliver such Right Certificates so countersigned; and in case at that
time any of the Right Certificates shall not have been countersigned, any successor Rights Agent may countersign such Right Certificates either in the name of the predecessor Rights Agent or in the name of the successor Rights Agent; and in all such
cases such Right Certificates shall have the full force provided in the Right Certificates and in this Agreement. 
  
 (b)    In case at any time the name of the Rights Agent shall be changed and at such time any of the Right Certificates shall have been countersigned but not delivered, the Rights Agent may adopt the
countersignature under its prior name and deliver Right Certificates so countersigned; and in case at that time any of the Right Certificates shall not have been countersigned, the Rights Agent may countersign such Right Certificates either in its
prior name or in its changed name and in all such cases such Right Certificates shall have the full force provided in the Right Certificates and in this Agreement. 
  
 Section 20.  Duties of Rights Agent.  The Rights Agent undertakes the duties and obligations imposed by this Agreement upon the following terms
and conditions, by all of which the Company and the holders of Right Certificates, by their acceptance thereof, shall be bound: 
  
 (a)    The Rights Agent may consult with legal counsel (who may be legal counsel for the Company), and the opinion of such counsel shall be full and complete authorization and protection to the Rights Agent as to
any action taken or omitted by it in good faith and in accordance with such opinion. 
  
 (b)    Whenever in the performance of its duties under this Agreement the Rights Agent shall deem it necessary or desirable that any fact or matter be proved or established by the Company prior to taking or
suffering any action hereunder, such fact or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved and established by a certificate signed by the Chairman of the Board and the
Secretary of the Company and delivered to the Rights Agent; and such certificate shall be full authorization to the Rights Agent for any action taken or suffered in good faith by it under the provisions of this Agreement in reliance upon such
certificate. 

 
 -25- 

 (c)    The Rights Agent shall be liable hereunder to the Company and any other Person only for its
own gross negligence or willful misconduct; provided, however, that under no circumstances shall the Rights Agent be liable for indirect, consequential, special or punitive damages. 
  
 (d)    The Rights Agent shall not be liable for or by reason of any of the statements of fact or recitals contained in this Agreement or in the Right
Certificates (except its countersignature thereof) or be required to verify the same, but all such statements and recitals are and shall be deemed to have been made by the Company only. 
  
 (e)    The Rights Agent shall not be under any responsibility in respect of the validity of this Agreement or the execution and delivery hereof (except
the due execution hereof by the Rights Agent) or in respect of the validity or execution of any Right Certificate (except its countersignature thereof); nor shall it be responsible for any breach by the Company of any covenant or condition contained
in this Agreement or in any Right Certificate; nor shall it be responsible for any change in the exercisability of the Rights (including the Rights becoming void pursuant to Section 11(a)(i) hereof) or any adjustment in the terms of the Rights
provided for in Sections 3, 11, 13, 23 and 24, or the ascertaining of the existence of facts that would require any such change or adjustment (except with respect to the exercise of Rights evidenced by Right Certificates after receipt of a
certificate furnished pursuant to Section 12, describing such change or adjustment); nor shall it by any act hereunder be deemed to make any representation or warranty as to the authorization or reservation of any shares of Common Stock or preferred
stock or other securities to be issued pursuant to this Agreement or any Right Certificate or as to whether any shares of Common Stock or other securities will, when issued, be validly authorized and issued, fully paid and nonassessable.

  
 (f)    The Company agrees that it will perform, execute, acknowledge and deliver or cause to
be performed, executed, acknowledged and delivered all such further and other acts, instruments and assurances as may reasonably be required by the Rights Agent for the carrying out or performing by the Rights Agent of the provisions of this
Agreement. 
  
 (g)    The Rights Agent is hereby authorized and directed to accept instructions
with respect to the performance of its duties hereunder from any person reasonably believed by the Rights Agent to be one of the Chairman of the Board or the Secretary of the Company, and to apply to such officers for advice or instructions in
connection with its duties, and it shall not be liable for any action taken or suffered by it in good faith in accordance with instructions of any such officer or for any delay in acting while waiting for those instructions. Any application by the
Rights Agent for written instructions from the Company may, at the option of the Rights Agent, set forth in writing any action proposed to be taken or omitted by the Rights Agent under this Agreement and the date on and/or after which such action
shall be taken or such omission shall be effective. The Rights Agent shall not be liable for any action taken by, or omission of, the Rights Agent in accordance with a proposal included in any such application on or after the date specified in such
application (which date shall not be less than five Business Days after the date any officer of the Company actually receives such application unless any such officer shall have consented in writing to an earlier date) unless, prior to taking

 
 -26- 

 any such action (or the effective date in the case of an omission), the Rights Agent shall have received written instructions in response to
such application specifying the action to be taken or omitted. 
  
 (h)    The Rights Agent and
any stockholder, director, officer or employee of the Rights Agent may buy, sell or deal in any of the Rights or other securities of the Company or become pecuniarily interested in any transaction in which the Company may be interested, or contract
with or lend money to the Company or otherwise act as fully and freely as though it were not Rights Agent under this Agreement. Nothing herein shall preclude the Rights Agent from acting in any other capacity for the Company or for any other legal
entity. 
  
 (i)    The Rights Agent may execute and exercise any of the rights or powers hereby
vested in it or perform any duty hereunder either itself or by or through its attorneys or agents, and the Rights Agent shall not be answerable or accountable for any act, default, neglect or misconduct of any such attorneys or agents or for any
loss to the Company resulting from any such act, default, neglect or misconduct, provided reasonable care was exercised in the selection and continued employment thereof. 
  
 (j)    If, with respect to any Rights Certificate surrendered to the Rights Agent for exercise or transfer, the certificate contained in the form of
assignment or the form of election to purchase set forth on the reverse thereof, as the case may be, has not been completed to certify the holder is not an Acquiring Person (or an Affiliate or Associate thereof) or transferee thereof, the Rights
Agent shall not take any further action with respect to such requested exercise or transfer without first consulting with the Company. 
  
 Section 21.  Change of Rights Agent.  The Rights Agent or any successor Rights Agent may resign and be discharged from its duties under this Agreement upon 30 days’ notice in writing mailed to
the Company and to each transfer agent of the Common Stock by registered or certified mail, and, following the Distribution Date, to the holders of the Right Certificates by first-class mail. The Company may remove the Rights Agent or any successor
Rights Agent upon 30 days’ notice in writing, mailed to the Rights Agent or successor Rights Agent, as the case may be, and to each transfer agent of the Common Stock by registered or certified mail, and, following the Distribution Date, to the
holders of the Right Certificates by first-class mail. If the Rights Agent shall resign or be removed or shall otherwise become incapable of acting, the Company shall appoint a successor to the Rights Agent. If the Company shall fail to make such
appointment within a period of 30 days after giving notice of such removal or after it has been notified in writing of such resignation or incapacity by the resigning or incapacitated Rights Agent or by the holder of a Right Certificate (who shall,
with such notice, submit his Right Certificate for inspection by the Company), then the registered holder of any Right Certificate may apply to any court of competent jurisdiction for the appointment of a new Rights Agent. Any successor Rights
Agent, whether appointed by the Company or by such a court, shall be a corporation organized and doing business under the laws of the United States or the laws of any state of the United States or the District of Columbia, in good standing, having
an office in the State of California or the State of New York, which is authorized under such laws to exercise corporate trust or stock transfer powers 

 
 -27- 

 and is subject to supervision or examination by federal or state authority and which has at the time of its appointment as Rights Agent a
combined capital and surplus of at least $50 million. After appointment, the successor Rights Agent shall be vested with the same powers, rights, duties and responsibilities as if it had been originally named as Rights Agent without further act or
deed; but the predecessor Rights Agent shall deliver and transfer to the successor Rights Agent any property at the time held by it hereunder, and execute and deliver any further assurance, conveyance, act or deed necessary for the purpose. Not
later than the effective date of any such appointment the Company shall file notice thereof in writing with the predecessor Rights Agent and each transfer agent of the Common Stock, and, following the Distribution Date, mail a notice thereof in
writing to the registered holders of the Right Certificates. Failure to give any notice provided for in this Section 21, however, or any defect therein, shall not affect the legality or validity of the resignation or removal of the Rights Agent or
the appointment of the successor Rights Agent, as the case may be. 
  
 Section 22.  Issuance of New
Right Certificates.  Notwithstanding any of the provisions of this Agreement or of the Rights to the contrary, the Company may, at its option, issue new Right Certificates evidencing Rights in such forms as may be approved by its Board
of Directors to reflect any adjustment or change in the Purchase Price and the number or kind or class of shares or other securities or property purchasable under the Right Certificates made in accordance with the provisions of this Agreement. In
addition, in connection with the issuance or sale of Common Stock following the Distribution Date and prior to the Expiration Date, the Company may with respect to shares of Common Stock so issued or sold pursuant to (i) the exercise of stock
options, (ii) under any employee plan or arrangement, (iii) upon the exercise, conversion or exchange of securities, notes or debentures issued by the Company or (iv) a contractual obligation of the Company, in each case existing prior to the
Distribution Date, issue Rights Certificates representing the appropriate number of Rights in connection with such issuance or sale. 
  
 Section 23.  Redemption. 
  
 (a)    The Board of
Directors of the Company may, at any time prior to the Flip-In Event, redeem all but not less than all the then outstanding Rights at a redemption price of $0.01 per Right, appropriately adjusted to reflect any stock split, stock dividend or similar
transaction occurring in respect of the Common Stock after the date hereof (the redemption price being hereinafter referred to as the “Redemption Price”). The redemption of the Rights may be made effective at such time, on such basis and
with such conditions as the Board of Directors of the Company in its sole discretion may establish. The Redemption Price shall be payable, at the option of the Company, in cash, shares of Common Stock, or such other form of consideration as the
Board of Directors of the Company shall determine. 
  
 (b)    Immediately upon the action of the
Board of Directors of the Company ordering the redemption of the Rights pursuant to paragraph (a) of this Section 23 (or at such later time as the Board of Directors of the Company may establish for the effectiveness of such redemption), and without
any further action and without any notice, the right to exercise the Rights will terminate and the only right thereafter of the holders of Rights shall be to receive 

 
 -28- 

 the Redemption Price. The Company shall promptly give public notice of any such redemption; provided, however, that the failure to
give, or any defect in, any such notice shall not affect the validity of such redemption. Within 10 days after such action of the Board of Directors of the Company ordering the redemption of the Rights (or such later time as the Board of Directors
of the Company may establish for the effectiveness of such redemption), the Company shall mail a notice of redemption to all the holders of the then outstanding Rights at their last addresses as they appear upon the registry books of the Rights
Agent or, prior to the Distribution Date, on the registry books of the transfer agent for the Common Stock. Any notice which is mailed in the manner herein provided shall be deemed given, whether or not the holder receives the notice. Each such
notice of redemption shall state the method by which the payment of the Redemption Price will be made. 
  
 Section
24.  Exchange. 
  
 (a)    The Board of Directors of the Company may, at its
option, at any time after the Flip-In Event, exchange all or part of the then outstanding and exercisable Rights (which shall not include Rights that have become void pursuant to the provisions of Section 11(a)(i) hereof) for Common Stock at an
exchange ratio of one share of Common Stock per Right, appropriately adjusted to reflect any stock split, stock dividend or similar transaction occurring in respect of the Common Stock after the date hereof (such amount per Right being hereinafter
referred to as the “Exchange Ratio”). Notwithstanding the foregoing, the Board of Directors of the Company shall not be empowered to effect such exchange at any time after an Acquiring Person shall have become the Beneficial Owner of
shares of Common Stock aggregating 50% or more of the shares of Common Stock then outstanding. From and after the occurrence of an event specified in Section 13(a) hereof, any Rights that theretofore have not been exchanged pursuant to this Section
24(a) shall thereafter be exercisable only in accordance with Section 13 and may not be exchanged pursuant to this Section 24(a). The exchange of the Rights by the Board of Directors of the Company may be made effective at such time, on such basis
and with such conditions as the Board of Directors of the Company in its sole discretion may establish. 
  
 (b)    Immediately upon the effectiveness of the action of the Board of Directors of the Company ordering the exchange of any Rights pursuant to paragraph (a) of this Section 24 and without any further action and
without any notice, the right to exercise such Rights shall terminate and the only right thereafter of a holder of such Rights shall be to receive that number of shares of Common Stock equal to the number of such Rights held by such holder
multiplied by the Exchange Ratio. The Company shall promptly give public notice of any such exchange; provided, however, that the failure to give, or any defect in, such notice shall not affect the validity of such exchange. The
Company shall promptly mail a notice of any such exchange to all of the holders of the Rights so exchanged at their last addresses as they appear upon the registry books of the Rights Agent. Any notice which is mailed in the manner herein provided
shall be deemed given, whether or not the holder receives the notice. Each such notice of exchange will state the method by which the exchange of the shares of Common Stock for Rights will be effected and, in the event of any partial exchange, the
number of Rights which will be exchanged. Any partial exchange shall be effected pro rata based on the 

 
 -29- 

 number of Rights (other than Rights which have become void pursuant to the provisions of Section 11(a)(i) hereof) held by each holder of Rights.

  
 (c)    The Company may at its option substitute, and, in the event that there shall not be
sufficient shares of Common Stock issued but not outstanding or authorized but unissued to permit an exchange of Rights for Common Stock as contemplated in accordance with this Section 24, the Company shall substitute to the extent of such
insufficiency, for each share of Common Stock that would otherwise be issuable upon exchange of a Right, a number of shares of Equivalent Common Shares (as such term is defined in Section 11(b)) having an aggregate current per share market price
(determined pursuant to Section 11(d) hereof) equal to the current per share market price of one share of Common Stock (determined pursuant to Section 11(d) hereof) as of the date of such exchange. 
  
 Section 25.  Notice of Certain Events. 
  
 (a)    In case the Company shall at any time after the earlier of the Distribution Date or the Stock Acquisition Date propose (i) to pay any dividend
payable in stock of any class to the holders of its Common Stock or to make any other distribution to the holders of its Common Stock (other than a regular cash dividend), (ii) to offer to the holders of its Common Stock rights or warrants to
subscribe for or to purchase any additional shares of Common Stock or shares of stock of any class or any other securities, rights or options, (iii) to effect any reclassification of its Common Stock (other than a reclassification involving only the
subdivision or combination of outstanding Common Stock), (iv) to effect the liquidation, dissolution or winding up of the Company, or (v) to effect a subdivision, combination or consolidation of the Common Stock (by reclassification or otherwise
than by payment of dividends in Common Stock), then, in each such case, the Company shall give to each holder of a Right Certificate, in accordance with Section 26 hereof, a notice of such proposed action, which shall specify the record date for the
purposes of such dividend, distribution or offering of rights or warrants, or the date on which such liquidation, dissolution, winding up, reclassification, subdivision, combination or consolidation is to take place and the date of participation
therein by the holders of the Common Stock, if any such date is to be fixed, and such notice shall be so given in the case of any action covered by clause (i) or (ii) above at least 10 days prior to the record date for determining holders of the
Common Stock for purposes of such action, and in the case of any such other action, at least 10 days prior to the date of the taking of such proposed action or the date of participation therein by the holders of the Common Stock, whichever shall be
the earlier. 
  
 (b)    In case any event described in Section 11(a)(i) or Section 13 shall occur
then the Company shall as soon as practicable thereafter give to each holder of a Right Certificate (or if occurring prior to the Distribution Date, the holders of the Common Stock) in accordance with Section 26 hereof, a notice of the occurrence of
such event, which notice shall describe such event and the consequences of such event to holders of Rights under Section 11(a)(i) and Section 13 hereof. 

 
 -30- 

  
 Section 26.  Notices.  Notices or demands authorized
by this Agreement to be given or made by the Rights Agent or by the holder of any Right Certificate to or on the Company shall be sufficiently given or made if sent by first-class mail, postage prepaid, addressed (until another address is filed in
writing with the Rights Agent) as follows: 
  
 DaVita Inc. 
 21250 Hawthorne Blvd. 
 Suite 800 
 Torrance, California 90503 
 Attention: Secretary 
  
 Subject to the provisions of Section 21 hereof, any notice or demand authorized by this Agreement to be given or made by the Company or by the holder of any Right Certificate to or on the Rights Agent
shall be sufficiently given or made if sent by first-class mail, postage prepaid, addressed (until another address is filed in writing with the Company) as follows: 
  
 The Bank of New York 
 101 Barclay Street – 11 East 
 New York, NY 10286 
 Attention: Stock Transfer Administration 

 
 Notices or demands authorized by this Agreement to be given or made by the Company or the Rights Agent to the holder of any Right Certificate shall be
sufficiently given or made if sent by first-class mail, postage prepaid, addressed to such holder at the address of such holder as shown on the registry books of the Company. 
  
 Section 27.  Supplements and Amendments.  Except as provided in the penultimate sentence of this Section 27, for so long as the Rights are then
redeemable, the Company may in its sole and absolute discretion, and the Rights Agent shall if the Company so directs, supplement or amend any provision of this Agreement in any respect without the approval of any holders of the Rights. At any time
when the Rights are no longer redeemable, except as provided in the penultimate sentence of this Section 27, the Company may, and the Rights Agent shall, if the Company so directs, supplement or amend this Agreement without the approval of any
holders of Rights, provided that no such supplement or amendment may (a) adversely affect the interests of the holders of Rights as such (other than an Acquiring Person or an Affiliate or Associate of an Acquiring Person), (b) cause this
Agreement again to become amendable other than in accordance with this sentence or (c) cause the Rights again to become redeemable. Notwithstanding anything contained in this Agreement to the contrary, no supplement or amendment shall be made which
changes the Redemption Price. Upon the delivery of a certificate from an appropriate officer of the Company which states that the supplement or amendment is in compliance with the terms of this Section 27, the Rights Agent shall execute such
supplement or amendment, provided that any supplement or amendment that does not change the rights and duties of the Rights Agent under this Agreement in a manner adverse to the Rights Agent shall become effective against all parties
immediately upon execution by the Company, whether or not also executed by the Rights Agent, and 

 
 -31- 

 provided further, that any supplement or amendment that changes the rights and duties of the Rights Agent under this Agreement in
a manner adverse to the Rights Agent shall become effective against the Rights Agent only upon the execution of such supplement or amendment by the Rights Agent. 
  
 Section 28.  Successors.  All the covenants and provisions of this Agreement by or for the benefit of the Company or the Rights Agent shall bind and inure to the benefit of
their respective successors and assigns hereunder. 
  
 Section 29.  Benefits of this
Agreement.  Nothing in this Agreement shall be construed to give to any Person other than the Company, the Rights Agent and the registered holders of the Right Certificates (and, prior to the Distribution Date, the Common Stock) any
legal or equitable right, remedy or claim under this Agreement; but this Agreement shall be for the sole and exclusive benefit of the Company, the Rights Agent and the registered holders of the Right Certificates (and, prior to the Distribution
Date, the Common Stock). 
  
 Section 30.  Determinations and Actions by the Board of
Directors.  The Board of Directors of the Company shall have the exclusive power and authority to administer this Agreement and to exercise the rights and powers specifically granted to the Board of Directors of the Company or to the
Company, or as may be necessary or advisable in the administration of this Agreement, including, without limitation, the right and power to (i) interpret the provisions of this Agreement and (ii) make all determinations deemed necessary or advisable
for the administration of this Agreement (including, without limitation, a determination to redeem or not redeem the Rights or to amend or not amend this Agreement). All such actions, calculations, interpretations and determinations that are done or
made by the Board of Directors of the Company in good faith shall be final, conclusive and binding on the Company, the Rights Agent, the holders of the Rights, as such, and all other parties. 
  

Section 31.  Severability.  If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction
or other authority to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Agreement shall remain in full force and effect and shall in no way be affected, impaired or invalidated.

  
 Section 32.  Governing Law.  This Agreement and each Right Certificate issued
hereunder shall be deemed to be a contract made under the laws of the State of Delaware and for all purposes shall be governed by and construed in accordance with the laws of the State of Delaware applicable to contracts to be made and performed
entirely within the State of Delaware; provided, however, that the rights, duties and responsibilities of the Rights Agent hereunder shall be governed by and construed in accordance with the laws of the State of New York. 
  
 Section 33.  Counterparts.  This Agreement may be executed in any number of counterparts and each of such
counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. 

 
 -32- 

 Section 34.  Descriptive Headings.  Descriptive headings of the several Sections of this
Agreement are inserted for convenience only and shall not control or affect the meaning or construction of any of the provisions hereof. 
  
 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed, all as of the day and year first above written. 
  
 DAVITA INC. 
  
 By:                                     
                                        
            
 Name:                                    
                                        
       
 Title:                                    
                                        
         
  
 BANK OF NEW YORK, 
 as Rights Agent 
  
 By:                                     
                                        
            
 Name:                                    
                                        
       
 Title:                                    
                                        
         

 
 -33- 

 Exhibit A 
  
 Form of Right Certificate 
  
 Certificate No.
R-                             
  
 
	 NOT EXERCISABLE AFTER NOVEMBER 14,
 2012 OR EARLIER IF REDEMPTION OR

EXCHANGE OCCURS. THE RIGHTS ARE
 SUBJECT TO REDEMPTION AT $0.01 PER
 RIGHT AND TO EXCHANGE ON THE TERMS
 SET FORTH IN THE RIGHTS AGREEMENT.
 UNDER
CERTAIN CIRCUMSTANCES, AS SET
 FORTH IN THE RIGHTS AGREEMENT, RIGHTS
 OWNED BY OR TRANSFERRED TO
ANY
 PERSON WHO IS OR BECOMES AN ACQUIRING
 PERSON (AS DEFINED IN THE RIGHTS
 AGREEMENT) AND CERTAIN TRANSFEREES
 THEREOF WILL BECOME NULL AND VOID
 AND WILL NO LONGER BE TRANSFERABLE.
 

 
  
 RIGHT CERTIFICATE 
  

DAVITA INC. 
  
 This certifies that
                                        
                                        
         or registered assigns, is the registered owner of the number of Rights set forth above, each of which entitles the owner thereof, subject to the terms, provisions and conditions of the Rights
Agreement, dated as of November 14, 2002, as the same may be amended from time to time (the “Rights Agreement”), between DaVita Inc., a Delaware corporation (the “Company”), and Bank of New York, as Rights Agent (the “Rights
Agent”), to purchase from the Company at any time after the Distribution Date (as such term is defined in the Rights Agreement) and prior to 5:00 P.M., New York City time, on November 14, 2012 at the office or agency of the Rights Agent
designated for such purpose, or of its successor as Rights Agent, one fully paid non-assessable share of common stock, par value $0.001 per share (the “Common Stock”), of the Company at a purchase price of $125.00 per share of Common Stock
(the “Purchase Price”), upon presentation and surrender of this Right Certificate with the Form of Election to Purchase duly executed. The number of Rights evidenced by this Rights Certificate (and the number of shares of Common Stock
which may be purchased upon exercise hereof) set forth above, and the Purchase Price set forth above, are the number and Purchase Price as of November 14, 2002 based on the Common Stock as constituted at such date. As provided in the Rights
Agreement, the Purchase Price, the number of shares of Common Stock (or preferred stock or other securities or property) which may be purchased upon the exercise of the Rights and 

 
 A-1 

 the number of Rights evidenced by this Right Certificate are subject to modification and adjustment upon the happening of certain events.

  
 This Right Certificate is subject to all of the terms, provisions and conditions of the Rights Agreement, which
terms, provisions and conditions are hereby incorporated herein by reference and made a part hereof and to which Rights Agreement reference is hereby made for a full description of the rights, limitations of rights, obligations, duties and
immunities hereunder of the Rights Agent, the Company and the holders of the Right Certificates. Copies of the Rights Agreement are on file at the principal executive offices of the Company and the above-mentioned office or agency of the Rights
Agent. The Company will mail to the holder of this Right Certificate a copy of the Rights Agreement without charge after receipt of a written request therefor. 
  
 This Right Certificate, with or without other Right Certificates, upon surrender at the office or agency of the Rights Agent designated for such purpose, may be exchanged for another Right Certificate
or Right Certificates of like tenor and date evidencing Rights entitling the holder to purchase a like aggregate number of shares of Common Stock as the Rights evidenced by the Right Certificate or Right Certificates surrendered shall have entitled
such holder to purchase. If this Right Certificate shall be exercised in part, the holder shall be entitled to receive upon surrender hereof another Right Certificate or Right Certificates for the number of whole Rights not exercised. 

 
 Subject to the provisions of the Rights Agreement, the Rights evidenced by this Certificate (i) may be redeemed by the Company
at a redemption price of $0.01 per Right or (ii) may be exchanged in whole or in part for shares of Common Stock, or shares of preferred stock or other equity securities of the Company. 
  
 No fractional shares of Common Stock will be issued upon the exercise or exchange of any Right or Rights evidenced hereby but in lieu thereof a cash payment will be made,
as provided in the Rights Agreement. 
  
 No holder of this Right Certificate, as such, shall be entitled to vote or
receive dividends or be deemed for any purpose the holder of the Common Stock or of any other securities of the Company which may at any time be issuable on the exercise or exchange hereof, nor shall anything contained in the Rights Agreement or
herein be construed to confer upon the holder hereof, as such, any of the rights of a stockholder of the Company or any right to vote for the election of directors or upon any matter submitted to stockholders at any meeting thereof, or to give or
withhold consent to any corporate action, or to receive notice of meetings or other actions affecting stockholders (except as provided in the Rights Agreement) or to receive dividends or subscription rights, or otherwise, until the Right or Rights
evidenced by this Right Certificate shall have been exercised or exchanged as provided in the Rights Agreement. 
  
 This Right Certificate shall not be valid or obligatory for any purpose until it shall have been countersigned by the Rights Agent. 
  

 
 A-2 

  
 WITNESS the facsimile signature of the proper officers of the Company and its
corporate seal. 
  
 Dated as of
[                                ,    ,
20    ]. 
  
 DAVITA INC. 
  
 By:                                     
                                        
                    
 Name:

 Title: 
  
 ATTEST:

                                      
                                        
       
 Name: 
 Title: 
  
 Countersigned: 
  
 BANK OF NEW YORK, as Rights Agent 
  
 By                                     
                                        
    
 Name: 
 Title: 

 
 A-3 

  
 Form of Reverse Side of Right Certificate 
  
 FORM OF ASSIGNMENT 
  
 (To be executed by the registered holder if such 
 holder desires to transfer the Right Certificate) 
  
 FOR VALUE RECEIVED
                                        
                                        
                         hereby sells, assigns and transfers
unto                                     
                                      
                                      
                                      
                     
                                      
                                        
                                        
                                        
                                        
                           
 (Please print name and address of transferee) 
  
              Rights represented by this Right Certificate, together with all right, title and interest therein, and does hereby irrevocably constitute and
appoint                                       
      Attorney, to transfer said Rights on the books of the within-named Company, with full power of substitution. 
  
 Dated:
                                        
           
  
                                      
                                        
                                        
        
 Signature 
 Signature
Guaranteed: 
  
 Signatures must be guaranteed by a bank, trust company, broker, dealer or other eligible institution
participating in a recognized signature guarantee medallion program. 
  
 ............................................................................................................................................................................. 
 (To be completed) 
  
 The undersigned hereby
certifies that the Rights evidenced by this Right Certificate are not beneficially owned by, were not acquired by the undersigned from, and are not being assigned to an Acquiring Person or an Affiliate or Associate thereof (as defined in the Rights
Agreement). 
  
                                      
                        
 Signature 
  

 
 A-4 

  
 Form of Reverse Side of Right Certificate—continued 
  
 FORM OF ELECTION TO PURCHASE 
  
 (To be executed if holder desires to exercise 
 Rights represented by the Rights Certificate) 
  
 To DAVITA INC.: 
  
 The undersigned hereby irrevocably elects to exercise              Rights represented by this Right Certificate to purchase the shares of Common Stock (or other
securities or property) issuable upon the exercise of such Rights and requests that certificates for such shares of Common Stock (or such other securities) be issued in the name of: 
                                      
                                        
                                        
                                        
                                        
                                        
                     
 (Please print name and address)

                                      
                                        
                                        
                                        
                                        
                                        
                     
  
 If such
number of Rights shall not be all the Rights evidenced by this Right Certificate, a new Right Certificate for the balance remaining of such Rights shall be registered in the name of and delivered to: 
  
 Please insert social security 
 or other identifying number 
                                      
                                        
                                        
                                        
                                        
                                        
                     
 (Please print name and address)

  
                                      
                                        
                                        
                                        
                                        
                                        
                     
  
 Dated:                                    
                                 
  

                                     
                                        
    
 Signature 
 (Signature must conform to holder specified on Right Certificate) 
  
 Signature Guaranteed: 
  
 Signature must be guaranteed by a bank, trust company, broker, dealer or other eligible institution participating in a recognized
signature guarantee medallion program. 

 
 A-5 

  
 Form of Reverse Side of Right Certificate—continued 
  
 
(To be completed) 
  
 The undersigned certifies that the Rights evidenced by this Right Certificate are not beneficially owned by, and were not acquired by the undersigned from, an Acquiring
Person or an Affiliate or Associate thereof (as defined in the Rights Agreement). 
  
                                      
                        
 Signature 
  
 
 
 NOTICE 
  
 The signature in the Form of Assignment or Form of Election to Purchase, as the
case may be, must conform to the name as written upon the face of this Right Certificate in every particular, without alteration or enlargement or any change whatsoever. 
  
 In the event the certification set forth above in the Form of Assignment or the Form of Election to Purchase, as the case may be, is not completed, such Assignment or
Election to Purchase will not be honored. 

 
 A-6 

  
 Exhibit B 
  
 UNDER CERTAIN CIRCUMSTANCES, AS SET 
 FORTH IN THE RIGHTS
AGREEMENT, 
 RIGHTS OWNED BY OR TRANSFERRED TO 
 ANY PERSON WHO IS OR BECOMES AN 
 ACQUIRING PERSON (AS DEFINED IN THE 
 RIGHTS AGREEMENT) AND CERTAIN 
 TRANSFEREES THEREOF WILL BECOME 
 NULL AND VOID AND WILL NO LONGER BE 
 TRANSFERABLE.

  
 SUMMARY OF RIGHTS TO PURCHASE 
 SHARES OF COMMON STOCK OF 
 DAVITA INC. 
  
 On November 14, 2002 the Board of Directors of DaVita Inc. (the “Company”) declared a dividend of one common share purchase right (a “Right”) for each outstanding share of common
stock, par value $0.001 per share, of the Company (the “Common Stock”). The dividend is payable on December 10, 2002 to the stockholders of record on November 29, 2002 (the “Record Date”). Each Right entitles the registered
holder to purchase from the Company one share of Common Stock, at a price of $125.00 per share of Common Stock (the “Purchase Price”), subject to adjustment. The description and terms of the Rights are set forth in a Rights Agreement,
dated as of November 14, 2002, as the same may be amended from time to time (the “Rights Agreement”), between the Company and The Bank of New York, as Rights Agent (the “Rights Agent”). 
  
 Until the earlier to occur of (i) 10 days following a public announcement that a person or group of affiliated or associated persons
(with certain exceptions, an “Acquiring Person”) has acquired beneficial ownership of 15% or more of the outstanding shares of Common Stock or (ii) 10 business days (or such later date as may be determined by action of the Board of
Directors of the Company prior to such time as any person or group of affiliated persons becomes an Acquiring Person) following the commencement of, or announcement of an intention to make, a tender offer or exchange offer the consummation of which
would result in the beneficial ownership by a person or group of 15% or more of the outstanding shares of Common Stock (the earlier of such dates being called the “Distribution Date”), the Rights will be evidenced, with respect to any of
the Common Stock certificates outstanding as of the Record Date, by such Common Stock certificate together with this Summary of Rights. 
  
 The Rights Agreement provides that, until the Distribution Date (or earlier expiration of the Rights), the Rights will be transferred with and only with the Common Stock. Until the Distribution Date (or earlier expiration of
the Rights), new Common Stock certificates issued after the Record Date upon transfer or new issuances of Common Stock will contain a notation incorporating the Rights Agreement by reference. Until the Distribution 

 
 B-1 

 Date (or earlier expiration of the Rights), the surrender for transfer of any certificates for shares of Common Stock outstanding as of the
Record Date, even without such notation or a copy of this Summary of Rights, will also constitute the transfer of the Rights associated with the shares of Common Stock represented by such certificate. As soon as practicable following the
Distribution Date, separate certificates evidencing the Rights (“Right Certificates”) will be mailed to holders of record of the Common Stock as of the close of business on the Distribution Date and such separate Right Certificates alone
will evidence the Rights. 
  
 The Rights are not exercisable until the Distribution Date. The Rights will expire on
November 14, 2012 (the “Final Expiration Date”), unless the Final Expiration Date is advanced or extended or unless the Rights are earlier redeemed or exchanged by the Company, in each case as described below. 
  
 The Purchase Price payable, and the number of shares of Common Stock or preferred stock or other securities or property issuable, upon
exercise of the Rights is subject to adjustment from time to time to prevent dilution (i) upon the grant to holders of the Common Stock of certain rights or warrants to subscribe for or purchase Common Stock at a price, or securities convertible
into Common Stock with a conversion price, less than the then-current market price of the Common Stock or (ii) upon the distribution to holders of the Common Stock, of evidences of indebtedness or assets (excluding regular periodic cash dividends or
dividends payable in Common Stock) or of subscription rights or warrants (other than those referred to above). 
  
 The number of outstanding Rights is subject to adjustment in the event of a stock dividend on the Common Stock payable in shares of Common Stock or subdivisions, consolidations or combinations of the Common Stock occurring, in any
such case, prior to the Distribution Date. 
  
 In the event that any person or group of affiliated or associated
persons becomes an Acquiring Person, each holder of a Right, other than Rights beneficially owned by the Acquiring Person (which will thereupon become void), will thereafter have the right to receive upon exercise of a Right that number of shares of
Common Stock having a market value of two times the exercise price of the Right. 
  
 In the event that, after a
person or group has become an Acquiring Person, the Company is acquired in a merger or other business combination transaction or 50% or more of its consolidated assets or earning power are sold, proper provisions will be made so that each holder of
a Right (other than Rights beneficially owned by an Acquiring Person which will have become void) will thereafter have the right to receive upon the exercise of a Right that number of shares of common stock of the person with whom the Company has
engaged in the foregoing transaction (or its parent) that at the time of such transaction have a market value of two times the exercise price of the Right. 
  
 At any time after any person or group becomes an Acquiring Person and prior to the earlier of one of the events described in the previous paragraph or the acquisition by such 

 
 B-2 

 Acquiring Person of 50% or more of the outstanding shares of Common Stock, the Board of Directors of the Company may exchange the Rights (other
than Rights owned by such Acquiring Person which will have become void), in whole or in part, for shares of Common Stock at an exchange ratio of one share of Common Stock per Right. 
  
 With certain exceptions, no adjustment in the Purchase Price will be required until cumulative adjustments require an adjustment of at least 1% in such Purchase Price. No
fractional shares of Common Stock will be issued and in lieu thereof an adjustment in cash will be made based on the current market price of the Common Stock. 
  
 At any time prior to the time an Acquiring Person becomes such, the Board of Directors of the Company may redeem the Rights in whole, but not in part, at a price of $0.01 per Right (the
“Redemption Price”) payable, at the option of the Company, in cash, shares of Common Stock or such other form of consideration as the Board of Directors of the Company shall determine. The redemption of the Rights may be made effective at
such time, on such basis and with such conditions as the Board of Directors of the Company in its sole discretion may establish. Immediately upon any redemption of the Rights, the right to exercise the Rights will terminate and the only right of the
holders of Rights will be to receive the Redemption Price. 
  
 For so long as the Rights are then redeemable, the
Company may, except with respect to the Redemption Price, amend the Rights Agreement in any manner. After the Rights are no longer redeemable, the Company may, except with respect to the Redemption Price, amend the Rights Agreement in any manner
that does not adversely affect the interests of holders of the Rights. 
  
 Until a Right is exercised or exchanged,
the holder thereof, as such, will have no rights as a stockholder of the Company, including, without limitation, the right to vote or to receive dividends. 
  
 A copy of the Rights Agreement has been filed with the Securities and Exchange Commission as an Exhibit to a Registration Statement on Form 8-A, dated [November
            , 2002]. A copy of the Rights Agreement is available free of charge from the Company. This summary description of the Rights does not purport to be complete and is qualified
in its entirety by reference to the Rights Agreement, as the same may be amended from time to time, which is hereby incorporated herein by reference. 

 
 B-3Settlement Agr General Release dtd 11/13/2002

 Exhibit 10.1 
  
  
 SETTLEMENT AGREEMENT AND GENERAL RELEASE 
  
 This Settlement Agreement and General Release (the “Agreement”) is entered into as of this 13th day of November 2002 (the “Effective Date”), by and among Cadence Design Systems, Inc. (“Cadence”), Joseph
Costello (“Costello”), Avant! Corporation LLC (“Avant!”), Gerald Hsu (“Hsu”), Eric Cheng (“Cheng”), Mitsuru Igusa (“Igusa”), and Synopsys, Inc. (“Synopsys”) (collectively “the
Parties”). 
  
 WHEREAS, Cadence filed a civil lawsuit in the United States District Court for the Northern
District of California (Case No. CV-95-20828 RMW) against Avant!, Hsu, Cheng, and Igusa, alleging, among other things, that they had misappropriated certain of Cadence’s trade secrets and infringed certain Cadence copyrights (“the
Lawsuit”); 
  
 WHEREAS, Avant! filed counterclaims in the Lawsuit against Cadence and Costello; 

 
 WHEREAS, Avant! became a wholly-owned subsidiary of Synopsys on June 6, 2002; 
  
 WHEREAS, the Parties desire to resolve on the terms set forth in this Agreement any and all pending actions and issues between them that
were asserted or could have been asserted in the Lawsuit without the further expenditure of time or expense of litigation; 
  
 NOW, THEREFORE, in consideration of the covenants, promises, releases and other consideration set forth herein, the Parties agree as follows: 
  
 TERMS AND CONDITIONS 
  
 1.    Definitions. 
  
 “Avant!, et al.” means
Avant!, Hsu, Cheng, and Igusa, severally and jointly, and each of their respective past, present and future representatives, heirs, executors, attorneys, agents, partners, officers, shareholders, directors, employees, consultants, parents,
subsidiaries, affiliates, divisions, successors, predecessors and assigns (limited, with respect to natural persons serving in any of the foregoing capacities, to such capacity), but not Synopsys. 
  
 “Avant! Permitted Information” means (a) Residual Information, (b) Cadence Confidential Information that (i) Avant!, et
al. possessed, took or otherwise appropriated from Cadence, et al. with or without authority on or before January 15, 1998; (ii) Avant!, et al. provided to Cadence, et al. in discovery or other proceedings in the Lawsuit; (iii) Avant! was permitted
to possess by the Protective Order or Preliminary Injunctions and to the extent provided for therein; or (iv) Avant!, et al. possessed, took or otherwise appropriated from Cadence, et al. with or without authority after January 15, 1998 through the
Merger Date that is 

 
 1 

  
 not Avant! Restricted Information; and (c) Cadence Confidential Information that is or may be inherent
in, is a derivative of, or is technology, a trade secret or an idea underlying, Cadence Confidential Information described in subparts (b) (i), (ii) or (iv) of this definition. Nothing in this Agreement shall be construed to grant Avant! or Synopsys
any right, license or freedom to use, license, sublicense, transfer, or disclose, at any time after the Effective Date, any information solely by virtue of its having been produced by Cadence in discovery in the Lawsuit. 
  
 “Avant! Restricted Information” means Cadence object code or source code that is Cadence Confidential Information and any
other material Cadence Confidential Information, including but not limited to software code transcribed from or prepared with contemporaneous reference to Cadence object code or source code that is Cadence Confidential Information, that Avant!, et
al. took or otherwise appropriated from Cadence, et al. after January 15, 1998 and through the Merger Date. 
  
 “Cadence, et al.” means Cadence and Costello, severally and jointly, and each of their respective past, present and future representatives, heirs, executors, attorneys, agents, partners, officers, shareholders,
directors, employees, parents, subsidiaries, affiliates, divisions, successors, predecessors and assigns (limited, with respect to natural persons serving in any of the foregoing capacities, to such capacity). 
  
 “Cadence Permitted Information” means (a) Residual Information, (b) Avant! Confidential Information that (i) Cadence, et
al. possessed, took or otherwise appropriated from Avant!, et al. with or without authority on or before January 15, 1998; (ii) Cadence, et al. provided to Avant!, et al. in discovery or other proceedings in the Lawsuit; (iii) Cadence was permitted
to possess by the Protective Order or Preliminary Injunctions and to the extent provided for therein; or (iv) Cadence, et al. possessed, took or otherwise appropriated from Avant!, et al. with or without authority after January 15, 1998 through the
Merger Date that is not Cadence Restricted Information; and (c) Avant! Confidential Information that is or may be inherent in, is a derivative of, or is technology, a trade secret or an idea underlying, Avant! Confidential Information described in
subparts (b) (i), (ii) or (iv) of this definition. Nothing in this Agreement shall be construed to grant Cadence any right, license or freedom to use, license, sublicense, transfer, or disclose, at any time after the Effective Date, any information
solely by virtue of its having been produced by Avant! in discovery in the Lawsuit. 
  
 “Cadence Restricted
Information” means Avant! object code or source code that is Avant! Confidential Information and any other material Avant! Confidential Information, including but not limited to software code transcribed from or prepared with
contemporaneous reference to Avant! object code or source code that is Avant! Confidential Information, that Cadence, et al. took or otherwise appropriated from Avant!, et al. after January 15, 1998 and through the Merger Date. 

 
 “Claims” means any and all manner of action, claim or cause of action (in law or in equity), suits, debts,
liens, contracts, agreements, promises, liabilities, demands, losses, damages, costs or expenses, including without limitation court costs and attorneys’ fees. 
  
 “Confidential Information” means (i) the products existing or under development on or before the Merger Date in object code and source code form of Avant!
and its subsidiaries or of Cadence and its subsidiaries; (ii) trade secrets relating to such products; and (iii) any other 

 
 2 

  
 information or materials marked or designated in writing by the owner as confidential; provided, however
that “Confidential Information” does not include information that: (a) is or becomes generally known or available by publication, commercial use or otherwise through no fault of the receiving Party; (b) became available to a Party on a
nonconfidential basis from a source (other than the other Party or its representatives) which such Party neither knew nor had reason to know was prohibited from disclosing such Confidential Information to the Party by a legal, contractual or
fiduciary obligation; (c) was in the Party’s possession prior to being furnished to it or its representatives by the other Party or its representatives, provided that the Party neither knew nor had reason to know that the sources of such
information was prohibited from disclosing the information to it by a legal, contractual or fiduciary obligation; (d) is independently developed by a Party without the use of Confidential Information; or (e) has been licensed to such Party by the
owner and is being used in a manner consistent with such license. 
  
 “Merger Date” means June 6,
2002, the closing date of Synopsys’ merger with Avant!. 
  
 “Preliminary Injunctions” means the
preliminary injunctions entered in the Lawsuit by orders of the United States District Court for the Northern District of California. 
  
 “Protective Order” means the protective order entered in the Lawsuit by order of the United States District Court for the Northern District of California on December 21, 1995, as amended. 

 
 “Released Claims” means the Claims released pursuant to sections 5(a) through (d) of this Agreement.

  
 “Residual Information” means Confidential Information, and any ideas, concepts, know-how or
techniques contained in such Confidential Information, that is retained in the memory without contemporaneous reference to such Confidential Information, the use of which as permitted herein shall be subject to the applicable copyright and patent
rights of the owner of such Confidential Information. 
  
 “Response Date” means a date no later than
thirty days from the receipt of an Unauthorized Use Notice. 
  
 “Settlement Payment” means the
payment provided for in section 2 of this Agreement. 
  
 “Synopsys, et al.” means Synopsys and each
of its past, present and future representatives, heirs, executors, attorneys, agents, partners, officers, shareholders, directors, employees, parents, subsidiaries, affiliates, divisions, successors, predecessors and assigns (limited, with respect
to natural persons serving in any of the foregoing capacities, to such capacity), but not Avant!. 
  
 “Unauthorized Use Damages” means the compensatory damages and/or disgorgement which Cadence proves it is entitled to receive under applicable law on account of a user’s unauthorized use of Avant! Restricted
Information, or which Avant! proves it is entitled to receive under applicable law on account of a user’s unauthorized use of Cadence Restricted 

 
 3 

  
 Information, calculated from the date the user of Avant! Restricted Information or Cadence Restricted
Information, as the case may be, responds in writing to the allegations of an Unauthorized Use Notice, until final resolution or final adjudication of any Claims based on the allegations of the Unauthorized Use Notice. 
  
 “Unauthorized Use Notice” means the notice provided for in section 7 of this Agreement. 
  
 2.    Settlement Payment.    The Settlement Payment shall be in the amount of two
hundred sixty five million dollars ($265,000,000), twenty million dollars ($20,000,000) of which shall be paid to Cadence on November 22, 2002, and two hundred forty-five million dollars of which ($245,000,000) shall be paid to Cadence on or before
December 16, 2002. With respect to the Settlement Payment, lost profits allegedly suffered by Cadence were not taken into account but were nevertheless waived as part of this Agreement. 
  
 3.    Dismissal.    Avant!, et al. and Cadence, et al. shall dismiss with prejudice the Lawsuit and all counterclaims
therein, and shall jointly file a stipulation seeking an order dissolving the Preliminary Injunctions, within one court day after Cadence’s receipt of the final payment required by section 2 of this Agreement. As part of those dismissals,
Avant!, et al. and Cadence, et al. shall jointly request that the District Court retain jurisdiction over the Lawsuit for the purpose of enforcing this Agreement. As of the Effective Date, and at its sole discretion, Avant! may seek a stay of all
proceedings in the Lawsuit, pending its dismissal, and all Parties will consent to such a stay. 
  
 4.    Representations. 
  
 (a)    Representations by Hsu, Cheng, and Igusa.    Each of Hsu, Cheng and Igusa severally represents that, as of the Effective Date (i) he does not possess any Cadence Confidential
Information other than Residual Information (and in the case of Igusa, information acquired after December 20, 2001); (ii) he has not, at any time, disclosed any source code or object code constituting Cadence Confidential Information to any other
person or entity (other than Avant!, et al.) but in the case of Igusa, as of December 20, 2001 and not as of the Effective Date; and (iii) other than Claims expressly excluded by the last sentence in Section 5(b), he is not aware of any Claim he
has, may have, or may have in the future against Cadence, et al., including but not limited to Claims for defamation or malicious prosecution, that is not released by this Agreement. 
  
 (b)    Representations by Avant!    Avant! represents that, as of the Merger Date, (i) Avant! did not possess any Avant!
Restricted Information; and (ii) no Avant! product contained Avant! Restricted Information; and as of the Effective Date, there is no Claim that Avant!, et al. has, may have, or may have in the future against Cadence, et al., including but not
limited to Claims for defamation or malicious prosecution, that is not released by this Agreement. 
  
 (c)    Representations by Synopsys.    Synopsys represents that, as of the Merger Date, (i) Avant! did not possess any Avant! Restricted Information; (ii) no Avant! product contained
Avant! Restricted Information; and (iii) Avant! had not disclosed to Synopsys any Avant! Restricted Information; and as of the Effective Date, there is no Claim that Avant!, et al. 

 
 4 

  
 has, may have, or may have in the future against Cadence, et al., including but not limited to Claims
for defamation or malicious prosecution, that is not released by this Agreement. 
  
 (d)    Representations by Cadence.    Cadence represents that, as of the Merger Date, (i) Cadence did not possess any Cadence Restricted Information; and (ii) no Cadence product
contained Cadence Restricted Information; and as of the Effective Date, there is no Claim that Cadence, et al. has, may have, or may have in the future against Avant!, et al. or Synopsys, et al., including but not limited to Claims for defamation or
malicious prosecution, that is not released by this Agreement; provided, however, that as applied to Synopsys, et al. this representation relates only to Claims that arise as a result of Synopsys’ ownership of Avant! or its development,
distribution, licensing or sale of products and technologies owned or possessed by Avant! as of the Merger Date, or the combination of such products with Synopsys’ products or derivative works thereof. 
  
 (e)    Representations by Costello.    Costello represents that, as of the Merger Date, (i)
Costello did not possess any Cadence Restricted Information; and (ii) he has not, at any time, given any Avant! Confidential Information to any other person or entity (other than Cadence); and as of the Effective Date, there is no Claim that
Costello has, may have, or may have in the future against Avant!, et al. or Synopsys, et al., including but not limited to claims for defamation or malicious prosecution, that is not released by this Agreement; provided, however, that as applied to
Synopsys, et al. this representation relates only to Claims that arise as a result of Synopsys’ ownership of Avant! or its development, distribution, licensing or sale of products and technologies owned or possessed by Avant! as of the Merger
Date, or the combination of such products with Synopsys’ products or derivative works thereof. 
  
 5.    Mutual Releases and Waivers. 
  
 (a)    Release By Cadence, et al. of Avant!, et al.    Cadence, et al. hereby forever and completely release and discharge Avant!, et al. of and from any and all Claims, known or
unknown, that Cadence, et al. (i) have made or could have made in the Lawsuit; (ii) had, have, or may have in the future against Avant!, et al. based on, arising out of, or relating to, conduct or events occurring, in whole or in part, before the
Merger Date or, in the case of Igusa, before December 20, 2001, including but not limited to Claims that Cadence, et al. had, have, or may have in the future based on, arising out of, or relating to, the possession, use, or disclosure of Avant!
Permitted Information and Avant! Restricted Information; provided that the past, current or future use of Avant! Restricted Information, shall not be released solely and exclusively to the extent of the remedies provided for in section 6(b) and
section 6(d) of this Agreement, and provided further that Claims for patent infringement shall not be released but shall be limited to the extent provided for in section 6(h) and section 7 of this Agreement. Notwithstanding the foregoing, the
releases in this subparagraph do not apply to any Claims, known or unknown, arising out of or related to Igusa’s current employment with Cadence or the negotiation thereof or, as against Igusa only, rights Cadence may have arising out of or
related to the acquisition of Silicon Perspective Corp. by Cadence. 
  
 (b)    Release by
Avant!, et al. of Cadence, et al.    Avant!, et al. hereby forever and completely release and discharge Cadence, et al. of and from any and all Claims, known or unknown, that Avant!, et al. (i) have made or could have
made in the Lawsuit, and (ii) had, have, 

 
 5 

  
 or may have in the future against Cadence, et al. based on or arising out of, or relating to conduct or
events occurring, in whole or in part, before the Merger Date or, in the case of Igusa, before December 20, 2001, including but not limited to Claims that Avant!, et al. had, have, or may have in the future relating to the possession, use, or
disclosure of Cadence Permitted Information and Cadence Restricted Information, provided that the past, current or future use of Cadence Restricted Information, shall not be released solely and exclusively to the extent of the remedies provided for
in section 6(c) and section 6(d) of this Agreement, and provided further that Claims for patent infringement shall not be released but shall be limited to the extent provided for in section 6(h) and section 7 of this Agreement. Notwithstanding the
foregoing, the releases in this subparagraph do not apply to any Claims, known or unknown, arising out of or related to Igusa’s current employment with Cadence or the negotiation thereof, or rights Igusa may have arising out of or related to
the acquisition of Silicon Perspective Corp. by Cadence. 
  
 (c)    Release by Cadence, et al.
of Synopsys, et al.    Cadence, et al. hereby forever and completely release and discharge Synopsys, et al. of and from any and all Claims, known or unknown, that Cadence, et al. had, have, or may have in the future based on,
arising out of, or relating to, any Claims released pursuant to section 5(a) of this Agreement. 
  
 (d)    Release by Synopsys, et al. of Cadence, et al.    Synopsys, et al. hereby forever and completely release and discharge Cadence, et al. of and from any and all Claims, known or
unknown, that Avant!, et al. had, have, or may have in the future based on, arising out of, or relating to, any Claims released pursuant to section 5(b) of this Agreement. 
  
 (e)    No release for obligations under this Agreement.    The Released Claims do not include any Claim that any Party may
have for a breach of any releasee’s obligations under this Agreement. 
  
 (f)    No
release of Claims for fraud in the inducement of this Agreement.    The Released Claims do not include any Claim that any Party may have for fraud in the inducement of this Agreement. 
  
 (g)    Treatment of Avant! Permitted Information and Cadence Permitted
Information.    Avant!, et al. shall treat Avant! Permitted Information, and Cadence, et al. shall treat Cadence Permitted Information, in a manner consistent with the manner in which it treats its own internally-generated
Confidential Information. 
  
 (h)    Waiver.    The Parties
acknowledge that they each may have Released Claims that are presently unknown and that the releases contained in this Agreement are (subject to their terms) intended to and will fully, finally, and forever discharge all Released Claims, whether now
asserted or unasserted, known or unknown. EACH PARTY EXPRESSLY UNDERSTANDS AND AGREES TO WAIVE THE PROVISIONS OF, AND RELINQUISH ALL RIGHTS AND BENEFITS AFFORDED BY, CALIFORNIA CIVIL CODE SECTION 1542, WHICH PROVIDES IN FULL AS FOLLOWS:

  
 A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS FAVOR
AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY 

 
 6 

  
 HIM MUST HAVE MATERIALLY AFFECTED HIS SETTLEMENT WITH THE DEBTOR.

  
 In making this waiver, the Parties acknowledge that they may hereafter discover facts in addition to or
different from those that they now believe to be true with respect to the subject matter released herein, but they agree that they have taken that possibility into account in reaching this Agreement and that, notwithstanding the discovery or
existence of any such additional or different facts, as to which they expressly assume the risk, they fully, finally, and forever settle and release, on the terms set forth in this Agreement, any and all such Released Claims, known or unknown,
suspected or unsuspected, contingent or non-contingent, whether or not concealed or hidden, that that Party had, has, or may have in the future, upon any theory of law or equity, including but not limited to conduct that is negligent, intentional,
with or without malice, or a breach of any duty, law or rule, without regard to the subsequent discovery or existence of such different or additional facts. 
  
 6.    Limitation of Remedies. 
  
 (a)    Generally.    Except as provided in section 6(b), section 6(c), section 6(d), section 6(f) or section 6(h) of this Agreement, the sole and exclusive remedy for any breach of a
representation by any Party shall be a claim against the breaching Party for any damages for, and/or an injunction to remedy, the injury caused by the breach. The Parties expressly understand that the breach of a representation by any Party or
Parties shall not operate to render this Agreement or any part of it void, voidable, or unenforceable. 
  
 (b)    Remedies for use of Avant! Restricted Information.    Except as provided in section 6(d), section 6(f) or section 6(h) of this Agreement, the sole and exclusive remedies for (i)
any breach by Avant! or Synopsys of their respective representations that, as of the Merger Date, no Avant! product contained Avant! Restricted Information; or (ii) any use of Avant! Restricted Information by Avant!, et al. or Synopsys, et al.
before, on or after the Merger Date, shall be (x) a Claim against the user of Avant! Restricted Information for a preliminary and/or permanent injunction against future use of such Avant! Restricted Information, as of the date such injunction is
entered, and (y) a Claim against the user for Unauthorized Use Damages. 
  
 (c)    Remedies
for use of Cadence Restricted Information.    Except as provided in section 6(d), section 6(f) or section 6(h) of this Agreement, the sole and exclusive remedies for (i) any breach by Cadence of its representations that, as
of the Merger Date, no Cadence product contained Cadence Restricted Information; or (ii) any use of Cadence Restricted Information by Cadence, et al. before, on or after the Merger Date, shall be (x) a Claim against the user of Cadence Restricted
Information for a preliminary and/or permanent injunction against future use of such Cadence Restricted Information, as of the date such injunction is entered, and (y) a Claim against the user for Unauthorized Use Damages. 
  
 (d)    Legal fees and costs in a proceeding pursuant to section 6(b) or section
6(c).    The prevailing party in a proceeding pursuant to section 6(b) or section 6(c) of this Agreement shall recover from the non-prevailing party the reasonable legal fees and costs that the prevailing party incurred in
pursuing its Claim. 

 
 7 

  
 (e)    OTHER THAN PURSUANT TO THE PROVISIONS OF
SECTION 6(b), SECTION 6(c), SECTION 6(d), SECTION 6(f) AND SECTION 6(h), AND OTHERWISE SUBJECT ONLY TO SECTION 5(e) AND 5(f) OF THIS AGREEMENT, NO PARTY, OR ITS AFFILIATES, OFFICERS, DIRECTORS, EMPLOYEES, AGENTS, SUCCESSORS OR ASSIGNS, SHALL BE
LIABLE TO ANY OTHER PARTY OR ANY OTHER PERSON FOR ANY REMEDY, INCLUDING BUT NOT LIMITED TO ANY COMPENSATORY, SPECIAL, EXEMPLARY, PUNITIVE, INCIDENTAL, MULTIPLE, DIRECT OR INDIRECT OR CONSEQUENTIAL DAMAGES, ARISING OUT OF THE USE OF THE AVANT!
RESTRICTED INFORMATION OR THE CADENCE RESTRICTED INFORMATION, AS THE CASE MAY BE. 
  
 (f)    Procedures relating to discovered or alleged use of Avant! Restricted Information and Cadence Restricted Information. 
  
 (i)    If Avant!, et al. or Synopsys, et al. determine that any one of them has used or is using Avant! Restricted Information, or if Cadence, et al.
determines that it has used or is using Cadence Restricted Information, it, he or they shall promptly cease any such use, and shall so inform Cadence, Avant! and Synopsys. 
  
 (ii)    If Cadence reasonably believes that Avant!, et al. or Synopsys, et al. has used or is using Avant! Restricted Information, and before filing any
action in any court in the United States or any other jurisdiction, Cadence shall deliver an Unauthorized Use Notice to the alleged user and, in all circumstances, Avant! and Synopsys, describing with particularity the basis for Cadence’s
belief, and requesting that such use cease. 
  
 (iii)    If Avant! or Synopsys reasonably
believes that Cadence, et al. has used or is using Cadence Restricted Information, and before filing any action in any court in the United States or any other jurisdiction, Avant! or Synopsys, as the case may be, shall deliver an Unauthorized Use
Notice to Cadence, describing with particularity the basis for Avant!’s or Synopsys’s belief, and requesting that such use cease. 
  
 (iv)    The recipient of an Unauthorized Use Notice shall make reasonable inquiry of the use alleged in the Unauthorized Use Notice, and shall respond to the Unauthorized Use Notice
before the Response Date corresponding to that Unauthorized Use Notice, with a copy to all recipients of the Unauthorized Use Notice. Such recipient shall not commence an action for declaratory relief with respect to the use alleged in the
Unauthorized Use Notice. If the response to the Unauthorized Use notice states that the recipient has ceased or intends to cease the use alleged within 90 days of such response (which period may be extended for an additional period of 90 days for
good cause shown), and thereafter timely certifies that such use has ceased, then the Party that delivered the Unauthorized Use Notice shall have no legal or equitable remedy whatever with respect to such use for so long the use does not recommence.
If the use recommences, or if the user has not genuinely ceased its allegedly unauthorized use, despite a certification, or if the response to the Unauthorized Use Notice states neither that the recipient has ceased nor intends to cease the use
alleged in the Unauthorized Use Notice, the sole and exclusive remedies of the sender of the Unauthorized Use Notice shall be as provided for in section 6(b), section 6(c) and section 6(d) of this Agreement. 

 
 8 

  
 (g)    Consequences of action pursuant to section
6(f).    No Party shall have a Claim or remedy for breach of a representation or otherwise with respect to any use of Avant! Restricted Information or Cadence Restricted Information that Avant!, et al. or Synopsys, et al., or
Cadence, et al., as the case may be, has ceased or ceases pursuant to section 6(f) of this Agreement. 
  
 (h)    Certain patent infringement treated in same manner as use of Avant! Restricted Information and use of Cadence Restricted Information.    (i) In the event that one or more elements
of an Avant! product, which element was first made, used or sold between January 15, 1998 and the Merger Date, infringes any U.S. or foreign patents owned by Cadence, et al., Cadence, et al.’s remedies with respect to such infringement shall be
the same, and the same procedures shall apply, as are provided for in this Agreement with respect to use of Avant! Restricted Information. 
  
 (ii)    In the event that one or more elements of a Cadence product, which element was first made, used or sold between January 15, 1998 and the Merger Date, infringes any U.S. or foreign patents
owned by Avant!, et al., Avant!, et al.’s remedies with respect to such infringement shall be the same, and the same procedures shall apply, as are provided for in this Agreement with respect to use of Cadence Restricted Information.

  
 (iii)    The foregoing provisions of this section 6(h) shall apply only to U.S. or foreign
patents that are owned by either Avant! et al. or Cadence et al. and are issued as of the Effective Date, and such U.S. or foreign patents for which applications or provisional applications were filed as of the Effective Date, and all continuations,
divisions, continuation-in-part, reissues or reexaminations thereof. 
  
 7.    License. 
  
 (a)    By
Cadence.    Cadence hereby grants to Avant! and Synopsys and their successors and assigns, in connection with the development, enhancement, sale, distribution and licensing of their products (including the disposition of
product lines in whole or part) or the provision of their services an irrevocable, perpetual, worldwide, fully paid up, royalty free, transferable, non-exclusive right and license to make, have made, import, use, sell, offer to sell, and reproduce
the Avant! Permitted Information in the past, present and future, and to copy, display, perform, execute, distribute, and prepare derivative works of the Avant! Permitted Information in the past, present and future, including the right to exercise
all of the foregoing rights in connection with such derivative works, and further including the right to sublicense others to do the same. The foregoing license does not permit the licensing or transfer of Avant! Permitted Information on its own and
not embedded in an Avant! or Synopsys product or embedded in a deliverable related to the provision of an Avant! or Synopsys service. 
  
 (b)    By Avant!.    Avant! hereby grants to Cadence and its successors and assigns, in connection with the development, enhancement, sale, distribution and licensing of their
products (including the disposition of product lines in whole or part) or the provision of their services an irrevocable, perpetual, worldwide, fully paid up, royalty free, transferable, non-exclusive right and license to make, have made, import,
use, sell, offer to sell, and reproduce the Cadence Permitted Information in the past, present and future, and to copy, display, perform, execute, distribute, and prepare derivative works of the Cadence Permitted Information in the 

 
 9 

  
 past, present and future, including the right to exercise all of the foregoing rights in connection with
such derivative works, and further including the right to sublicense others to do the same. The foregoing license does not permit the licensing or transfer of Cadence Permitted Information on its own and not embedded in a Cadence product or embedded
in a deliverable related to the provision of a Cadence service. 
  
 (c)    Cadence Patent
Licenses.    Cadence hereby grants to Avant! and Synopsys and their successors and assigns, in connection with the development, enhancement, sale, distribution and licensing of their products (including the disposition of
product lines in whole or part) an irrevocable, perpetual, worldwide, fully paid up, royalty free, transferable, non-exclusive right and license to make, have made, import, use, sell, offer to sell, and reproduce, in the past, present and future,
elements of each Avant! product,, which elements were made, used or sold by Avant! on or before January 15, 1998, that infringes any U.S. or foreign letter patent owned by Cadence. The foregoing license applies only to the use of such elements as
incorporated in an Avant! or Synopsys product. 
  
 (d)    Avant! Patent
Licenses.    Avant! hereby grants to Cadence and its successors and assigns, in connection with the development, enhancement, sale, distribution and licensing of its products (including the disposition of product lines in
whole or part) an irrevocable, perpetual, worldwide, fully paid up, royalty free, transferable, non-exclusive right and license to make, have made, import, use, sell, offer to sell, and reproduce, in the past, present and future, elements of each
Cadence product, which elements were made, used or sold by Cadence on or before January 15, 1998, that infringes any U.S. or foreign letter patent owned by Avant!. The foregoing license applies only to the use of such elements as incorporated in a
Cadence product. 
  
 (e)    Limitation on Patent Licenses.    The
foregoing patent licenses shall apply only to U.S. or foreign patents that are owned by either Avant! et al. or Cadence et al. and are issued as of the Effective Date, and such U.S. or foreign patents for which applications or provisional
applications were filed as of the Effective Date, and all continuations, divisions, continuations-in-part, reissues and reexaminations thereof. 
  
 8.    Public Statements/Confidentiality.    The Parties agree that Synopsys and Cadence will issue a joint statement in the form of Exhibit A to
this Agreement (the “Public Statement”). Except in connection with the prosecution or defense of a claim or potential claim, the Parties agree to refrain from making any public comment on this Agreement beyond stating objectively
ascertainable facts contained either in this Agreement or the Public Statement, except as required by applicable law or regulation. 
  
 9    Compliance with the Protective Order.    The Parties shall comply with paragraph 9.5 of the Protective Order upon dismissal of the Lawsuit pursuant to this
Agreement, except that the attorneys of record each shall be permitted to retain one copy of the pleadings and any Protected Materials provided by a Producing Party, as those terms are defined in the Protective Order, to the extent reasonably
necessary to enforce section 6, section 7 and the provisions of this Agreement relating to use of Avant! Restricted Information or Cadence Restricted Information. 
  
 10.    Waiver or Amendment.    The Parties agree that any amendment, supplement, modification, waiver, or termination
of this Agreement (a “Modification”) shall not be valid or 

 
 10 

  
 binding unless executed in writing by all of the Parties to this Agreement affected by such
Modification. The waiver of any breach or default will not constitute the waiver of any other right hereunder or any subsequent breach or default. Any Modification involving a change in the Settlement Payment shall require the consent of Illinois
National Insurance Company, insurer of Synopsys. Consent to any Modification shall be at the sole discretion of the entity giving such consent. 
  
 11.    Representation by Counsel.    The Parties hereby acknowledge that each has been represented by counsel throughout all negotiations which
preceded the execution of this Agreement and that this Agreement has been executed with the consent and advice of counsel. 
  
 12.    Joint Preparation.    The language of all parts of this Agreement shall in all cases be construed as a whole, according to its fair meaning, and not strictly for or against
any of the Parties. This Agreement was prepared jointly by the Parties, and no presumptions or rules of interpretation based upon the identity of the party preparing or drafting the Agreement, or any part thereof, shall be applicable or invoked.

  
 13.    Entire Agreement.    This Agreement supersedes any
and all other prior agreements and negotiations between Cadence, et al. on the one hand, and Avant!, et al. and Synopsys, et al. on the other hand, leading up to the execution of this Agreement on the subject matter herein (but not Igusa’s 2001
employment agreement with Cadence), whether oral or in writing, and Cadence, et al. on the one hand, and Avant!, et al. and Synopsys, et al. on the other hand, and each of them, acknowledge that no representations, inducements, promises or
statements, oral or otherwise, have been made which are not embodied or incorporated by reference herein, and further agree that no other agreement, covenant, representation, inducement, promise or statement not set forth in writing in this
Agreement shall be valid or binding. This Agreement contains the entire agreement of Cadence, et al., on the one hand, and Avant!, et al. and Synopsys, et al., on the other hand, and supersedes all prior negotiations, correspondence, understandings,
letters of intent or agreements between them. 
  
 14.    Governing
Law.    This Agreement shall be governed by and construed and interpreted in accordance with the laws of the State of California. 
  
 15.    Attorneys’ Fees.    Each of Cadence, et al., Avant!, et al. and Synopsys, et al. shall bear its own attorneys’ fees and costs
incurred as a result of the Lawsuit, except to the extent that Avant! has previously compensated Cadence for its attorneys’ fees pursuant to the judgment entered in People v. Avant!, et al., Santa Clara Superior Court Case No. 21A570.

  
 16.    Authority.    Each Party represents and warrants for
himself or itself that the individual executing this Agreement on his or its behalf is authorized to do so and to bind the Party on whose behalf the individual is signing. The Parties further represent and warrant that each is the sole holder of the
Claims being released in this Agreement, that he or it has not assigned those Claims to any other person, and that no one else has any Claim, title or interest in or to the Claims being released herein. 
  
 17.    Headings.    The headings of this Agreement are included for convenience only
and shall not be deemed to constitute part of this Agreement or to affect its construction. 
  

 
 11 

 18.    Counterparts.    This Agreement may be executed in
counterparts, each of which shall be deemed an original, and all of which together shall constitute one and the same instrument. 
  
 19.    Facsimile Signatures.    This Agreement may be executed by facsimile, which shall be deemed an original; provided, however, that original signatures shall also be provided
by all signatories hereto. 
  
 20.    Effect of
Agreement.    This Agreement shall be binding upon and inure to the benefit of the Parties, and their respective attorneys, insurers, representatives, heirs, descendants, dependents, executors, spouses and successors.
This Agreement shall not be admissible in any proceeding as evidence regarding the truth or falsity of any allegation in the Lawsuit. 
  
  
  
 
	 CADENCE DESIGN SYSTEMS, INC.:
 	 	 AVANT! CORPORATION LLC:
 
	 
	 By:
 	 	 /s/    R.L. SMITH MCKEITHEN
 
	 	 By:
 	 	 /s/    STEVEN SHEVICK
 

	 
	 JOSEPH COSTELLO
 	 	 SYNOPSYS, INC.:
 
	 
	 /s/    JOSEPH COSTELLO
 
	 	 By:
  
 	 	 /s/    AART DE GEUS
 

	 
	 GERALD HSU
 	 	 ERIC CHENG
 
	 
	 /s/    GERALD HSU
 
	 	 /s/    ERIC CHENG
 

	 
	 MITSURU IGUSA
 	 	  	 	  	 	  
	 
	 /s/    MITSURU IGUSA
 
	 	  	 	  	 	  

 
  

 
 12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00045-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00045-of-00352.parquet"}]]